Clinical Protocols
Resuscitation / Life Support
Basic Life Support (BLS)
Sudden Cardiac Arrest Management Mapping.
- Assessment: Establish scene safety; check for responsiveness and normal breathing (or agonal gasps).
- Activation: Activate the emergency response system and request an Automated External Defibrillator (AED) immediately.
- Circulation: Initiate high-quality chest compressions at a rate of 100–120/min and a depth of 5–6 cm (2–2.4 inches).
- Airway & Breathing: Open the airway and provide rescue breaths at a 30:2 compression-to-ventilation ratio for untrained or single-rescuer providers.
- Defibrillation: Attach the AED as soon as available; minimize time to rhythm analysis and follow voice prompts for shock delivery.
- Compression Quality: Minimize all pauses in compressions to < 10 seconds and ensure full chest wall recoil between each compression.
Advanced Cardiac Life Support (ACLS)
Pulseless Arrest Management Mapping.
- CPR Quality: Initiate continuous, high-quality chest compressions at a rate of 100–120/min with full chest recoil; switch compressors every 2 minutes to prevent fatigue.
- Rhythm Assessment: Attach the monitor/defibrillator immediately to identify rhythm morphology and determine the shock-delivery strategy.
- VF/pVT Algorithm: If Ventricular Fibrillation (VF) or pulseless Ventricular Tachycardia (pVT):
- Shock → 2 min CPR → Shock → 2 min CPR + Epinephrine (1 mg) → Shock → Amiodarone (300 mg bolus, then 150 mg).
- PEA/Asystole Algorithm: If Pulseless Electrical Activity (PEA) or Asystole:
- Administer Epinephrine (1 mg) as soon as feasible; continue 2-minute CPR loops and re-evaluate the rhythm every 2 minutes.
- Interruption Management: Minimize absolute pauses in chest compressions to less than 10 seconds during all rhythm checks, pulse checks, and medication administration.
Pediatric Advanced Life Support (PALS)
Pediatric Resuscitation & Cardiorespiratory Arrest Mapping.
- Assessment: Identify impending respiratory failure or shock through rapid physiological assessment (Pediatric Assessment Triangle: Appearance, Work of Breathing, Circulation).
- CPR Technique: Initiate high-quality chest compressions at a 15:2 ratio for two-rescuer infant/child scenarios (30:2 for single rescuers); ensure a rate of 100–120/min.
- Defibrillation (VF/pVT): Deliver weight-adjusted shocks: 2 J/kg for the first shock, escalating to 4 J/kg (max 10 J/kg or adult dose) for subsequent shocks.
- Epinephrine: Administer IV/IO Epinephrine 0.01 mg/kg (0.1 mL/kg of the 1:10,000 concentration) every 3–5 minutes.
- Antiarrhythmic Therapy: Administer Amiodarone 5 mg/kg bolus or Lidocaine 1 mg/kg for refractory Ventricular Fibrillation (VF) or pulseless Ventricular Tachycardia (pVT).
- Volume Resuscitation: Administer 20 mL/kg boluses of isotonic crystalloids for hypovolemic or distributive shock, reassessing frequently for pulmonary edema.
Advanced Trauma Life Support (ATLS)
Polytrauma Assessment & Primary Survey Mapping.
- A - Airway: Establish and maintain a patent airway while providing rigid cervical spine stabilization.
- B - Breathing: Verify ventilation and oxygenation; perform immediate needle decompression or chest tube placement if tension pneumothorax or other life-threatening thoracic pathology is identified.
- C - Circulation: Control active hemorrhage via direct pressure or tourniquets; establish large-bore IV access and initiate resuscitation with blood products (avoid excessive crystalloids).
- D - Disability: Conduct a rapid neurological assessment using the Glasgow Coma Scale (GCS) and evaluate pupillary reactivity.
- E - Exposure/Environment: Completely expose the patient to facilitate a thorough exam, then immediately implement warming measures (blankets, warm fluids) to prevent the "lethal triad" of trauma (acidosis, coagulopathy, hypothermia).
- Re-evaluation: Continuously monitor and re-assess the patient's physiological response to interventions before transitioning to a formal head-to-toe secondary survey.
Post–Cardiac Arrest Care Protocol
ROSC Stabilization & Neuroprotection Pathway Mapping.
- Oxygenation & Ventilation: Optimize respiratory parameters to maintain SpO2 92–98% and PaCO2 35–45 mmHg; avoid hyperoxia via careful FiO2 titration.
- Hemodynamic Optimization: Support systemic perfusion using balanced fluid boluses and vasopressors (e.g., norepinephrine) to target a Mean Arterial Pressure (MAP) ≥ 65 mmHg.
- Cardiac Evaluation: Obtain an immediate 12-lead ECG to screen for ST-Elevation Myocardial Infarction (STEMI); activate the cardiac catheterization team if indicated.
- Targeted Temperature Management (TTM): Initiate TTM between 32°C and 36°C for patients remaining non-responsive after Return of Spontaneous Circulation (ROSC).
- Neurological Management: Maintain continuous EEG monitoring to detect status epilepticus; treat seizures promptly with anti-epileptics.
- Prognostication: Postpone clinical neuro-prognostication metrics for at least 72 hours post-rewarming completion to allow for medication clearance and neurological stabilization.
Shock & Critical Care Resuscitation
Undifferentiated Shock Management Protocol
Hemodynamic Collapse Differential Diagnostics Mapping.
- Monitoring: Establish continuous invasive arterial pressure monitoring and ensure reliable central venous access for vasopressor delivery.
- Bedside Diagnostics: Perform a hyper-acute RUSH (Rapid Ultrasound in Shock) protocol to evaluate the "Pump" (heart), "Tank" (volume/IVC), and "Pipe" (vessels/aorta) profiles.
- Etiology Differentiation: Rapidly classify hypoperfusion into cardiogenic, distributive (e.g., septic/anaphylactic), hypovolemic, or obstructive (e.g., PE/tamponade) states.
- Fluid Stewardship: Administer fluid challenges cautiously only if an underfilled "tank" is identified via ultrasound and the absence of pulmonary congestion (B-lines) is confirmed.
- Vasopressor Support: Initiate early norepinephrine to restore systemic vascular resistance and maintain adequate coronary/cerebral perfusion pressures.
- Metabolic Tracking: Correct acid-base imbalances and monitor arterial lactate levels every 2 hours to assess the efficacy of tissue perfusion recovery.
Septic Shock Protocol
Systemic Sepsis Resuscitation Bundle Mapping.
- Diagnostics: Draw blood cultures from two separate sites (at least one percutaneous) and measure serum lactate levels immediately to assess global tissue perfusion.
- Antimicrobials: Administer broad-spectrum empiric antimicrobials within 60 minutes of recognizing septic shock.
- Fluid Resuscitation: Deliver a rapid bolus of 30 mL/kg of balanced crystalloids for patients presenting with persistent hypotension or an initial lactate ≥ 4 mmol/L.
- Vasopressors: Initiate Norepinephrine via a central venous catheter as the first-line agent to maintain a mean arterial pressure (MAP) target ≥ 65 mmHg.
- Refractory Management: Add Vasopressin (0.03 units/min) if the MAP remains refractory despite optimized catecholamine titration.
- Lactate Clearance: Re-measure serum lactate profiles every 2–4 hours to confirm downward clearance kinetics and gauge treatment efficacy.
Massive Transfusion Protocol (MTP)
Exsanguinating Hemorrhage Hemostatic Control Mapping.
- Activation: Activate the institutional MTP for massive, uncontrolled hemorrhage; request the first cooler of blood products (typically uncrossmatched O-negative or low-titer O-positive blood).
- Ratio-Driven Resuscitation: Administer blood products in a balanced 1:1:1 ratio (1 unit PRBCs : 1 unit FFP : 1 unit Platelets) to mitigate dilutional coagulopathy.
- Hemostatic Adjuncts: Administer Tranexamic Acid (TXA) 1g IV loading dose within the first 3 hours of injury to stabilize fibrin clots.
- Damage Control Surgery: Coordinate immediate surgical or interventional radiology source control for hemorrhage, as volume replacement is only a bridge to mechanical hemostasis.
- Metabolic Monitoring: Monitor for ionized hypocalcemia (citrate toxicity) and acidosis; aggressively rewarm the patient to prevent the coagulopathy of trauma.
- Goal-Directed Therapy: Utilize point-of-care viscoelastic testing (e.g., TEG/ROTEM) to guide specific factor replacement (fibrinogen concentrate, cryoprecipitate).
Hemorrhagic Shock / Trauma Resuscitation Protocol
Traumatic Exsanguination Permissive Hypotension Mapping.
- Mechanical Hemostasis: Deploy external tourniquets, pelvic binders, and wound packing interfaces immediately to achieve source control.
- Permissive Hypotension: Implement a permissive hypotension philosophy, targeting a systolic BP of 80–90 mmHg or a MAP of 60–65 mmHg to prevent "popping the clot."
- Pharmacologic Stabilization: Administer Tranexamic Acid (TXA) 1g IV loading dose over 10 minutes, followed by 1g IV infusion over 8 hours (must be administered within 3 hours of injury).
- Fluid Restriction: Strictly restrict large crystalloid fluid boluses to avoid dilutional coagulopathy and the disruption of developing fibrin clots.
- Balanced Resuscitation: Transition early to balanced blood component therapy (e.g., 1:1:1 ratio) to aggressively treat trauma-induced coagulopathy.
- Thermal Protection: Maintain systemic warmth (active rewarming) to disrupt the progression of the "Lethal Triad" (Acidosis, Coagulopathy, Hypothermia).
Anaphylactic Shock Protocol
IgE-Mediated Systemic Hypersensitivity Intervention Mapping.
- Eliminate Trigger: Terminate exposure to the suspected inciting allergen or therapeutic agent immediately.
- Primary Intervention: Administer Epinephrine (1:1000) 0.3–0.5 mg IM into the anterolateral thigh without delay. This is the definitive life-saving intervention.
- Airway Management: Secure the airway early if signs of impending obstruction appear, such as stridor, progressive tongue/laryngeal edema, or hoarseness.
- Supportive Care: Deliver high-flow oxygen and infuse large-bore crystalloid fluid boluses (1–2 L) to manage distributive shock and vasodilation.
- Secondary Therapy: Administer adjunct medications: H1/H2 blockers (e.g., Diphenhydramine 50 mg, Famotidine 20 mg) and corticosteroids (e.g., Methylprednisolone 125 mg) to mitigate late-phase reactions.
- Refractory Shock: If hemodynamic instability persists despite IM epinephrine, establish a continuous IV epinephrine infusion and monitor closely for arrhythmias.
Airway & Ventilation
Airway Management Algorithm
Sequential Respiratory Optimization & Intubation Mapping.
- Patient Positioning: Optimize the geometry of the airway using the sniffing position or ramped mechanics (for obese patients) to align the axes.
- Pre-oxygenation: Utilize non-rebreather masks combined with high-flow nasal cannula (NODESAT) to maximize oxygen reserve and lengthen safe apnea times.
- Instrumentation: Select the laryngoscope platform (direct or video laryngoscopy) based on patient anatomy and provider expertise.
- Intubation: Visualize the glottic opening and pass the endotracheal tube (ETT) under direct or indirect vision.
- Verification: Confirm ETT placement immediately using continuous waveform capnography ($EtCO_2$) and auscultation of bilateral breath sounds.
- Post-Intubation Management: Secure the tube, inflate the cuff to appropriate pressure (20–30 cm H2O), and connect the patient to a mechanical ventilator with appropriate settings.
Rapid Sequence Intubation (RSI) Protocol
Emergency Paralytic Induction & Airway Protection Mapping.
- Pre-Intubation Assessment: Conduct a systematic airway evaluation using the LEMON criteria (Look externally, Evaluate 3-3-2 rule, Mallampati score, Obstruction, Neck mobility).
- Optimization: Pre-oxygenate for 3 minutes using high-flow nasal cannula or non-rebreather mask to replace functional residual capacity (FRC) nitrogen with oxygen.
- Induction: Administer a rapid-acting sedative: Etomidate (0.3 mg/kg) for hemodynamic stability, or Ketamine (1.5–2 mg/kg) if reactive airway disease or hypotension is present.
- Neuromuscular Blockade: Follow immediately with a paralytic: Succinylcholine (1.5 mg/kg) for quick onset/offset, or Rocuronium (1.2 mg/kg) if longer duration is required or contraindications to succinylcholine exist.
- Minimize Gastric Insufflation: Avoid bag-valve-mask (BVM) ventilation unless necessary to maintain oxygen saturation > 90% (e.g., using "gentle" ventilation with PEEP).
- Instrumentation: Place the endotracheal tube (ETT) only after full muscular relaxation is confirmed (typically 45–60 seconds).
Difficult Airway Algorithm
Anticipated & Unanticipated Complex Airway Strategy Mapping.
- Risk Assessment: Identify difficult airway indicators (e.g., facial hair, limited mouth opening, micrognathia, or cervical spine immobility).
- Preparation: Stage rescue equipment (video laryngoscope, bougie, and supraglottic airway device) at the bedside prior to induction.
- Oxygenation: Maintain continuous oxygenation support (e.g., high-flow nasal oxygen) throughout all visualization attempts.
- Attempt Limitation: Limit individual direct laryngoscopy (DL) attempts to a maximum of two before switching to alternative modalities to prevent soft tissue trauma.
- Escalation Strategy: Transition immediately to a video laryngoscopy (VL) platform or insert a supraglottic device (e.g., LMA) if initial glottic views are suboptimal.
- Surgical Rescue: Proceed directly to an emergent surgical airway (e.g., needle or surgical cricothyrotomy) if oxygenation and ventilation cannot be maintained via glottic or supraglottic routes ("Cannot Intubate, Cannot Oxygenate" scenario).
Failed Airway / Cannot Intubate–Cannot Ventilate Protocol
Emergency Subglottic Airway Access Mapping.
- Declaration: Explicitly declare a "Cannot Intubate, Cannot Ventilate" (CICV) emergency status to the entire resuscitation team to trigger immediate escalation.
- Supraglottic Rescue: Insert a supraglottic device (e.g., LMA, King LT) as an immediate temporizing maneuver to establish an airway.
- Ventilation Optimization: If supraglottic fails, perform optimized two-person bag-mask ventilation with the insertion of oral and nasal pharyngeal airways to maximize seal and patency.
- Surgical Preparation: If oxygenation saturation remains unrecoverable, immediately expose and palpate the anterior neck to identify the cricothyroid membrane.
- Emergency Surgical Airway: Execute a scalpel-bougie-tube cricothyroidotomy: make a vertical skin incision, horizontal incision through the cricothyroid membrane, dilate with a bougie, and pass an appropriately sized ETT (usually 6.0 mm).
- Verification: Confirm placement via direct tube visualization, chest rise, bilateral breath sounds, and continuous waveform capnography ($EtCO_2$).
Mechanical Ventilation Initial Settings Protocol
Initial Circuit Configuration & Lung Protection Mapping.
- Weight Estimation: Compute the patient's Ideal Body Weight (IBW) using height and biological sex (standard formulas such as the Devine formula). This is the foundation of lung-protective ventilation.
- Ventilation Mode: Select the primary mode: Volume Control (VC-CMV) for consistent minute ventilation or Pressure Control (PC-CMV) for controlled peak airway pressures.
- Tidal Volume (Vt): Set initial tidal volumes strictly to 6–8 mL/kg of calculated IBW. (Use 6 mL/kg for patients with ARDS).
- Respiratory Rate (RR): Program the rate to 12–16 breaths per minute, adjusting based on the patient's baseline pH and PaCO2.
- Oxygenation & PEEP: Titrate FiO2 to achieve SpO2 92–98% or PaO2 60–80 mmHg; initiate baseline PEEP at 5 cm H2O.
- Assessment: Obtain an arterial blood gas (ABG) at 30–60 minutes post-initiation to evaluate minute ventilation and acid-base status.
ARDS Lung-Protective Ventilation Protocol
Refractory Hypoxemic Lung-Protective Circuit Mapping.
- Tidal Volume (Vt): Reduce tidal volume settings to 4–6 mL/kg of Ideal Body Weight (IBW) to minimize overdistension.
- Pressure Limits: Maintain plateau pressures (Pplat) strictly below 30 cm H2O.
- PEEP Titration: Utilize the ARDSnet PEEP/FiO2 table to titrate PEEP, balancing lung recruitment against the risk of hemodynamic compromise.
- Permissive Hypercapnia: Accept rising PaCO2 levels as long as the systemic pH remains ≥ 7.20, allowing the lungs time to clear CO2 without excessive minute ventilation.
- Driving Pressure (DP): Target a driving pressure (DP = Pplat – PEEP) of < 15 cm H2O to minimize cyclic lung stretch.
- Advanced Rescue: Initiate early prone positioning (at least 16 hours/day) if the PaO2/FiO2 ratio remains < 150 despite optimized mechanical ventilation.
Weaning from Mechanical Ventilation Protocol
Ventilator Discontinuation Readiness Screening Mapping.
- Insult Resolution: Verify resolution or significant improvement of the primary respiratory or systemic insult that necessitated mechanical ventilation.
- Hemodynamic Stability: Confirm stable cardiovascular metrics: low or stable vasopressor requirements and intact neurological reflexes.
- Oxygenation Criteria: Assess readiness via FiO2 ≤ 40% and PEEP ≤ 8 cm H2O while maintaining acceptable arterial blood gas parameters.
- Respiratory Capacity: Test baseline respiratory performance: confirm spontaneous tidal volume (Vt) > 5 mL/kg of Ideal Body Weight (IBW).
- Airway Patency: Screen for an active cough reflex and verify manageable upper airway secretion volume to minimize post-extubation failure.
- Spontaneous Breathing Trial (SBT): Transition the eligible patient to an SBT pathway (e.g., T-piece or Pressure Support) if all preceding metrics are satisfied.
Spontaneous Breathing Trial (SBT) Protocol
Extubation Readiness Diagnostic Challenge Mapping.
- Circuit Configuration: Adjust ventilator settings to minimal support, typically Pressure Support (PS) of 5–7 cm H2O or a direct T-piece trial.
- Monitoring Duration: Allow the patient to breathe spontaneously for a target duration of 30–120 minutes.
- Tolerance Indicators: Assess clinical status: ensure Respiratory Rate (RR) remains < 35/min, Heart Rate (HR) changes are < 20%, and SpO2 ≥ 90%.
- Clinical Observation: Monitor for signs of distress, including diaphoresis, accessory respiratory muscle recruitment, or altered mental status.
- Rapid Shallow Breathing Index (RSBI): Compute the RSBI (RR divided by Vt in liters) at the 30-minute mark to assess breathing efficiency.
- Extubation Planning: Proceed to extubation planning if RSBI < 105 and no clinical signs of respiratory distress are noted.
Non-Invasive Ventilation (NIV) Protocol
Positive-Pressure Mask Interventions Mapping.
- Interface Selection: Select the appropriate interface (oronasal or nasal mask) sizing to guarantee an airtight mask-to-face fit.
- Mode Selection: Utilize CPAP for acute cardiogenic pulmonary edema to provide airway stenting; utilize BiPAP for hypercapnic respiratory failure (e.g., COPD exacerbations) to assist in CO2 clearance.
- Initial Parameters: Program baseline settings: Inspiratory Positive Airway Pressure (IPAP) 10–12 cm H2O and Expiratory Positive Airway Pressure (EPAP) 4–5 cm H2O.
- Titration: Titrate IPAP upward (typically 15–20 cm H2O) to decrease the patient's work of breathing and improve tidal volume (Vt).
- Tolerance & Monitoring: Evaluate patient comfort, compliance, and skin integrity over bony facial structures (e.g., nasal bridge) to prevent pressure necrosis.
- Rescue Strategy: Maintain a low threshold for endotracheal intubation if gas exchange parameters deteriorate or if the patient's mental status declines despite NIV.
High-Flow Nasal Cannula (HFNC) Escalation Protocol
Humidified High-Flow Oxygen Titration & Monitoring Mapping.
- Application: Apply the specialized high-flow nasal cannula device, ensuring correct prong orientation and secure positioning to prevent skin breakdown.
- Initial Configuration: Initiate gas flow rates at 40–50 L/min with the FiO2 initially set at 100% to address acute hypoxemia.
- Temperature: Adjust the heated humidifier settings between 31°C and 37°C to maximize patient comfort and mucociliary clearance.
- Titration: Titrate flow upward to 60 L/min if respiratory rate parameters remain elevated (indicating persistent work of breathing).
- Monitoring: Calculate the ROX Index ([SpO2/FiO2] / Respiratory Rate) at 2, 6, and 12 hours post-initiation.
- Rescue Strategy: Maintain a low threshold for early intubation if the ROX index falls below 4.88, as this indicates a high risk for HFNC failure.
Cardiovascular Emergencies
Acute Coronary Syndrome (ACS) Protocol
Ischemic Chest Pain Clinical Triage Mapping.
- Diagnostic ECG: Obtain and analyze a diagnostic 12-lead ECG trace within 10 minutes of patient arrival to identify ST-elevation (STEMI).
- Primary Antiplatelet: Administer non-enteric coated Aspirin 162–325 mg orally, instructing the patient to chew it for rapid systemic absorption.
- Baseline Labs: Secure intravenous access and immediately send samples for high-sensitivity cardiac troponins.
- Nitrate Therapy: Provide sublingual Nitroglycerin 0.4 mg every 5 minutes (up to 3 doses), ensuring no contraindications exist (e.g., hypotension, phosphodiesterase inhibitor use).
- Oxygenation: Supplement oxygen only if hypoxemia is verified via SpO2 < 90%.
- Adjuvant Therapy: Administer secondary antiplatelet agents (e.g., Ticagrelor or Clopidogrel) and initiate systemic anticoagulation (e.g., Heparin) per institutional protocols.
STEMI Reperfusion Protocol
Hyper-acute Myocardial Infarction Reperfusion Track Mapping.
- Identification: Identify ST-segment elevations across ≥ 2 anatomically contiguous leads on a 12-lead ECG.
- Team Activation: Activate the cardiac catheterization laboratory immediately via a single-call notification code.
- PCI Strategy: Maintain target door-to-balloon intervals strictly under 90 minutes for primary Percutaneous Coronary Intervention (PCI).
- Fibrinolytic Pathway: Prepare fibrinolytic therapy (e.g., Alteplase, Tenecteplase) if transport to a PCI-capable center exceeds 120 minutes.
- Fibrinolytic Timing: Ensure delivery of fibrinolytic therapeutics within a door-to-needle target of 30 minutes.
- Post-Reperfusion: Administer systemic antithrombotics and provide transfer/admission to a specialized cardiac care unit for continuous monitoring.
Tachyarrhythmia Management Protocol
Symptomatic Narrow & Wide Complex Tachycardia Mapping.
- Hemodynamic Assessment: Assess stability immediately: identify hypotension, acutely altered mental status, signs of shock, or ischemic chest pain.
- Unstable Management: If unstable, perform immediate synchronized cardioversion (Narrow-regular: 50–100 J; Wide-regular: 100 J).
- Stable Narrow-Regular: Perform vagal maneuvers; if ineffective, administer Adenosine 6 mg rapid IV push (followed by 12 mg if needed).
- Stable Narrow-Irregular: (e.g., Atrial Fibrillation) Titrate IV Beta-blockers or Diltiazem to achieve ventricular rate control.
- Stable Wide-Regular: Consider Adenosine if the rhythm is SVT with aberrancy (monomorphic); otherwise, infuse Amiodarone 150 mg over 10 minutes.
- Expert Consultation: Obtain cardiology consultation for complex dysrhythmias or suspected ventricular tachycardia (VT).
Bradycardia Management Protocol
Symptomatic Severe Bradycardic Stabilization Mapping.
- Hemodynamic Assessment: Evaluate for signs of inadequate perfusion: altered mental status, signs of shock, or severe hypotension.
- Pharmacologic First-Line: Administer Atropine 1 mg IV push every 3–5 minutes, up to a maximum dose of 3 mg.
- Transcutaneous Pacing (TCP): If Atropine is ineffective (or contraindicated), initiate TCP immediately while preparing for definitive measures.
- Verification: Adjust pacing output (current) until electrical capture (wide QRS complex, broad T wave) and mechanical capture (palpable pulse) are confirmed.
- Alternative Infusions: Initiate continuous infusion of Dopamine (5–20 mcg/kg/min) or Epinephrine (2–10 mcg/min) to support heart rate and blood pressure.
- Definitive Management: Coordinate urgent placement of a temporary transvenous pacemaker wire for patients with high-degree heart blocks.
Hypertensive Emergency Protocol
Acute End-Organ Damage Blood Pressure Titration Mapping.
- Hemodynamic Monitoring: Establish intra-arterial blood pressure monitoring to accurately map continuous Mean Arterial Pressure (MAP) variations.
- Organ Assessment: Evaluate for acute target organ complications, including aortic dissection, acute ischemic/hemorrhagic stroke, or hypertensive encephalopathy.
- Titration Speed: Reduce MAP by no more than 20–25% within the first hour using titratable continuous IV infusions.
- Intermediate Targets: Target a blood pressure reduction toward 160/100 mmHg over the subsequent 2–6 hours.
- Pharmacology: Utilize short-acting, easily titratable infusions (e.g., Labetalol, Nicardipine, or Esmolol).
- Aortic Dissection Exception: Rapidly lower SBP to < 120 mmHg within 20 minutes for confirmed acute aortic dissection to limit shear stress on the vessel wall.
Acute Heart Failure / Pulmonary Edema Protocol
Decompensated Ventricular Congestion Fluid Management Mapping.
- Ventilatory Support: Apply high-flow oxygen and initiate non-invasive positive pressure ventilation (NIV/BiPAP) to decrease work of breathing and improve intrathoracic pressure.
- Vasodilation: Administer sublingual Nitroglycerin to establish rapid venous and arterial vasodilation, reducing preload and afterload.
- Diuresis: Infuse bolus intravenous loop diuretics (e.g., Furosemide 20–40 mg, or 1–2.5 times the patient's daily home dose equivalent).
- Nitrate Infusion: Initiate a continuous Nitroglycerin infusion starting at 10–20 mcg/min, titrating upward aggressively to manage elevated afterload.
- Monitoring: Track hourly urine output, serum electrolyte shifts, and serial respiratory rate profiles to assess volume status.
- Inotropic Support: Consider positive inotropic agents (e.g., Milrinone or Dobutamine) if the patient exhibits a low-output cardiogenic state (e.g., hypotension/hypoperfusion).
Pulmonary Embolism Management Protocol
Thromboembolic Risk Stratification & Occlusion Mapping.
- Risk Stratification: Utilize clinical decision tools such as the Wells Score and the Pulmonary Embolism Severity Index (PESI) to categorize risk profiles.
- Diagnostic Imaging: Obtain a CT Pulmonary Angiogram (CTA) to confirm diagnosis, or perform a bedside echocardiogram to evaluate for signs of Right Ventricular (RV) strain/dilation.
- Standard Anticoagulation: Initiate therapeutic anticoagulation (e.g., Unfractionated Heparin or LMWH) for hemodynamically stable patients.
- Unstable Classification: Monitor closely for hypotension or signs of obstructive shock, which classify the PE as "Massive."
- Advanced Intervention: Administer systemic thrombolytic therapy (e.g., Alteplase 100 mg IV) if obstructive shock or cardiac arrest develops.
- Surgical/Mechanical Rescue: Contact interventional radiology or cardiothoracic surgery for catheter-directed mechanical thrombectomy or ECMO if systemic thrombolysis is contraindicated.
Neurologic Emergencies
Stroke Code Protocol
Hyper-acute Ischemic Stroke Interventional Mapping.
- Assessment: Compute the formal NIHSS score and establish the precise "last known normal" (LKN) timeline.
- Imaging: Perform a non-contrast head CT within 20 minutes of arrival to rule out intracranial hemorrhage.
- Metabolic Screening: Check point-of-care blood glucose immediately to exclude hypoglycemia as a stroke mimic.
- Thrombolysis: If eligible, administer IV Alteplase (0.9 mg/kg) or Tenecteplase within the 3–4.5 hour window from symptom onset.
- Blood Pressure Control: Maintain blood pressure targets < 185/110 mmHg prior to and during thrombolytic administration.
- Vascular Imaging: Coordinate immediate CTA (Angiography) and CTP (Perfusion) mapping to assess for Large Vessel Occlusion (LVO) and suitability for mechanical thrombectomy.
Intracerebral Hemorrhage (ICH) Protocol
Hemorrhagic Stroke Expansion Mitigation Mapping.
- Triage & Imaging: Obtain an urgent non-contrast head CT and transfer to a specialized neurological ICU for continuous monitoring.
- Coagulopathy Reversal: Identify and reverse all antiplatelet or anticoagulant agents immediately using targeted antidotes.
- Reversal Agents: Administer Four-Factor Prothrombin Complex Concentrate (PCC) and Vitamin K for Warfarin reversal; utilize Idarucizumab or Andexanet alfa for direct oral anticoagulants (DOACs).
- Blood Pressure Management: Lower elevated systolic blood pressure rapidly to a target range of 130–140 mmHg via continuous IV infusion (e.g., Nicardipine) to reduce the risk of hematoma expansion.
- ICP Management: Elevate the head of the bed to 30° and screen for clinical signs of intracranial hypertension (e.g., Cushing’s triad) or impending herniation.
- Surgical Consultation: Consult neurosurgery immediately to evaluate the need for urgent hematoma evacuation or external ventricular drain (EVD) placement.
Subarachnoid Hemorrhage (SAH) Protocol
Aneurysmal Rupture Stabilization & Vasospasm Prophylaxis Mapping.
- Diagnosis: Confirm subarachnoid hemorrhage (SAH) via non-contrast CT; utilize lumbar puncture for xanthochromia assessment if clinical suspicion remains high despite a negative initial CT.
- Hemodynamic Stability: Enforce strict bed rest, implement aggressive analgesia, and utilize stool softeners to prevent Valsalva maneuvers that elevate intracranial pressure.
- Rebleed Prophylaxis: Maintain Systolic Blood Pressure (SBP) strictly below 160 mmHg to minimize the risk of aneurysmal rebleeding.
- Vasospasm Prophylaxis: Initiate Nimodipine 60 mg orally (or via nasogastric tube) every 4 hours to reduce delayed ischemic neurological deficits (DINDs).
- Anatomical Localization: Obtain urgent CT angiography (CTA) or Digital Subtraction Angiography (DSA) to identify the aneurysm for coiling or clipping.
- Hydrocephalus Management: Insert an External Ventricular Drain (EVD) promptly if acute hydrocephalus develops to relieve intracranial pressure.
Status Epilepticus Protocol
Refractory Convulsive Seizure Termination Mapping.
- Stabilization: Protect the patient’s physical safety, optimize airway management with high-flow O2, and immediately check bedside blood glucose levels to rule out hypoglycemia.
- First-Line Pharmacotherapy: Administer IV Lorazepam (4 mg) or IM Midazolam (10 mg) if IV access is delayed.
- Redosing: Repeat the first-line benzodiazepine dose one time if convulsive patterns persist after 5 minutes.
- Second-Line Antiepileptic Drugs (AEDs): Simultaneously initiate loading doses of non-benzodiazepine AEDs: Levetiracetam (60 mg/kg) or Fosphenytoin (20 mg PE/kg).
- Refractory Management: If status persists > 20 minutes, transition to continuous anesthetic infusions (e.g., Propofol or Midazolam) to achieve seizure suppression.
- Continuous Monitoring: Establish continuous Video EEG (vEEG) monitoring to verify the suppression of electrical seizures and detect subclinical seizure variants.
Traumatic Brain Injury (TBI) Protocol
Intracranial Traumatic Insult Secondary Mitigation Mapping.
- Assessment: Compute the Glasgow Coma Scale (GCS) score; secure the airway via endotracheal intubation if GCS ≤ 8 ("GCS less than 8, intubate").
- Oxygenation: Aggressively prevent hypoxemia, maintaining arterial pO2 > 60 mmHg (or SpO2 > 90–92%) to prevent secondary ischemic injury.
- Hemodynamics: Avoid systemic hypotension; titrate IV fluids and vasopressors to maintain Systolic Blood Pressure (SBP) ≥ 100–110 mmHg.
- Positioning: Maintain neutral cervical-spine alignment and elevate the head of the bed (HOB) to 30° to facilitate venous drainage.
- Imaging: Obtain urgent non-contrast head CT to evaluate for midline shift, intracranial hemorrhage (ICH), or extra-axial hematomas.
- Ventilation: Avoid prophylactic hyperventilation during the first 24 hours, as it causes cerebral vasoconstriction; utilize only for acute, signs of impending herniation.
Intracranial Hypertension Management Protocol
Elevated Intracranial Pressure Tiered Rescue Mapping.
- Monitoring: Establish invasive ICP monitoring; target Intracranial Pressure (ICP) strictly < 22 mm Hg.
- General Measures: Elevate the head of the bed (HOB) to 30°–45° and maintain neutral neck alignment to optimize venous outflow.
- Analgo-Sedation: Ensure adequate sedation and analgesia (e.g., Propofol and Fentanyl continuous infusions) to reduce metabolic demand and prevent agitation-induced ICP spikes.
- Hyperosmolar Therapy: Administer bolus doses of 3% Hypertonic Saline (250 mL) or 20% Mannitol (0.5–1 g/kg) to draw fluid from the brain parenchyma into the intravascular space.
- CSF Drainage: If an External Ventricular Drain (EVD) is present, perform controlled CSF drainage based on real-time pressure waveform triggers.
- Emergent Rescue: Implement short-term hyperventilation (target PaCO2 30–35 mm Hg) only as a temporary bridge to definitive interventions.
- Advanced Tiers: Escalation to advanced therapies, including pentobarbital coma, therapeutic hypothermia, or decompressive craniectomy, should be considered if first-tier measures fail.
Metabolic / Endocrine Emergencies
Diabetic Ketoacidosis (DKA) Protocol
Hyperglycemic Metabolic Acidosis Correction Mapping.
- Fluid Resuscitation: Initiate aggressive fluid volume expansion using 0.9% Normal Saline at 15–20 mL/kg/hr to restore circulatory volume.
- Potassium Assessment: Check serum potassium immediately; do not start insulin if potassium levels measure < 3.3 mEq/L, as insulin will drive potassium into cells and cause life-threatening arrhythmias.
- Insulin Therapy: Start Regular Insulin infusions at 0.1 units/kg/hr only after confirming potassium levels exceed 3.3 mEq/L.
- Potassium Repletion: Add 20–30 mEq of Potassium to each liter of IV fluid to maintain serum potassium metrics between 4.0–5.0 mEq/L.
- Glucose Management: Transition fluids to D5-containing solutions (e.g., D5W + 0.45% NaCl) when serum glucose trends below 250 mg/dL to prevent hypoglycemia.
- Resolution Criteria: Continue insulin infusions until the anion gap closes, bicarbonate levels improve, and arterial pH normalizes.
Hyperosmolar Hyperglycemic State (HHS) Protocol
Profound Hyperosmolar Resuscitation & Hydration Mapping.
- Fluid Resuscitation: Prioritize correction of profound volume deficits (often 8–10 liters total) by administering 1–2 liters of isotonic crystalloids (0.9% NaCl) in the first hour.
- Sodium Correction: Calculate corrected serum sodium metrics (Corrected Na = Measured Na + 1.6 × [Glucose - 100] / 100) to guide the shift from isotonic to hypotonic (0.45% NaCl) fluids.
- Insulin Therapy: Administer low-dose continuous insulin (starting at 0.05 units/kg/hr) to gradually lower glucose levels.
- Glucose Titration: Target a controlled decline in blood glucose at a rate of 50–75 mg/dL per hour to avoid rapid fluid shifts into the CNS.
- Electrolyte Management: Track calculated serum osmolality shifts and supplement potassium if serum values drop below 5.0 mEq/L.
- Clinical Stability: Maintain steady hydration rates to prevent cardiovascular collapse during the rapid correction of hyperosmolality.
Hypoglycemia Emergency Protocol
Acute Neuro-Glycopenic Resuscitation Mapping.
- Rapid Screening: Check point-of-care capillary blood glucose immediately for any presentation of altered mental status, diaphoresis, or focal neurological deficits.
- Oral Replacement: If the patient is conscious and able to swallow, administer 15–20 grams of rapid-acting oral carbohydrates (e.g., fruit juice, glucose gel).
- IV Dextrose: If obtunded, vomiting, or unable to safely swallow, administer 1 ampule of 50% Dextrose (D50W, 25g) intravenously.
- Alternative Route: Administer 1 mg of IM Glucagon if intravenous access cannot be established promptly.
- Monitoring: Recheck blood glucose levels every 15 minutes until values consistently remain above 70 mg/dL.
- Maintenance: Initiate a continuous 10% Dextrose (D10W) infusion if hypoglycemia is recurrent or caused by long-acting agents like sulfonylureas.
Hyperkalemia Emergency Protocol
Severe Hyperkalemic Cardioprotection & Elimination Mapping.
- Cardiac Screening: Obtain an immediate 12-lead ECG to screen for cardiotoxicity signs: peaked T waves, PR interval prolongation, or QRS complex widening.
- Membrane Stabilization: Administer 10% Calcium Gluconate 1–2g IV over 5–10 minutes to antagonize the membrane effects of potassium.
- Intracellular Shifting: Administer 10 units of Regular Insulin IV alongside 50 mL of D50W to drive potassium into the intracellular space.
- Adjuvant Shifting: Administer continuous nebulized Albuterol (10–20 mg) to augment the insulin-mediated potassium shift.
- Acidosis Correction: Administer IV Sodium Bicarbonate (50 mEq) only if concurrent severe metabolic acidosis is present.
- Systemic Elimination: Enhance potassium removal via loop diuretics (e.g., Furosemide), potassium binders (e.g., Patiromer, Sodium Zirconium Cyclosilicate), or emergent hemodialysis.
Hyponatremia Correction Protocol
Dysnatremic Osmotic Demyelination Prevention Mapping.
- Assessment: Classify hyponatremia based on clinical volume status and serum osmolality to distinguish between hypo-, eu-, and hypervolemic states.
- Symptomatic Rescue: For acute or severe symptomatic cases (e.g., seizures, altered mental status), administer a 100 mL bolus of 3% Hypertonic Saline IV.
- Redosing: Repeat 3% hypertonic saline boluses up to 2 times as necessary if neurological symptoms persist.
- Correction Velocity: For chronic hyponatremia, restrict the rate of serum sodium correction strictly to < 8 mEq/L within any 24-hour window.
- Free Water Management: Implement strict fluid (free water) restriction protocols for hypervolemic or euvolemic presentations (e.g., SIADH).
- Monitoring: Meticulously monitor serum sodium concentrations every 2–4 hours during hypertonic saline administration to ensure compliance with correction limits.
Hypernatremia Correction Protocol
Free Water Deficit Resuscitation Mapping.
- Deficit Calculation: Compute the total body free water deficit based on the patient's lean body weight and current serum sodium measurement.
- Correction Rate: Target a slow, controlled decline in sodium; aim for < 0.5 mEq/L per hour (maximum 10–12 mEq/L per day) to prevent iatrogenic complications.
- Hypotonic Administration: Administer free water via enteral routes (if the patient has a functional gut) or D5W infusions intravenously.
- Serial Monitoring: Monitor serum sodium levels every 4 hours to verify the correction trajectory remains within the safe range.
- Dynamic Adjustment: Reduce the rate of free water administration if the down-trend pace accelerates, as rapid drops in serum sodium can induce cerebral edema.
- Hemodynamic Stability: Switch to 0.45% Normal Saline (1/2 NS) if concurrent volume depletion requires both hypovolemic resuscitation and free water repletion.
Thyroid Storm Protocol
Hyperthyroid Metabolic Crisis Multiphase Inhibition Mapping.
- Beta-Blockade: Initiate immediate adrenergic control using IV Esmolol or Propranolol (60–80 mg orally every 6 hours) to manage tachycardia and end-organ stress.
- Synthesis Inhibition: Administer Propylthiouracil (PTU) 500–1000 mg loading dose, followed by 250 mg every 4 hours to block thyroid hormone synthesis.
- Iodine Therapy: Wait at least 60 minutes after PTU administration before infusing iodine (e.g., Lugol's solution, 5 drops every 6 hours) to block hormone release.
- Peripheral Conversion Blockade: Administer Hydrocortisone (100 mg IV every 8 hours) to inhibit the peripheral conversion of T4 to the more active T3.
- Supportive Care: Implement aggressive cooling measures (e.g., cooling blankets). Avoid aspirin-based antipyretics, as they can displace thyroid hormone from binding proteins.
- Clinical Monitoring: Transfer to ICU for hemodynamic support and search for precipitating factors, most commonly infection.
Myxedema Coma Protocol
Severe Decompensated Hypothyroid Critical Resuscitation Mapping.
- Airway Management: Secure the airway early if respiratory drive is impaired, hypercapnia is present, or the patient has a decreased level of consciousness.
- Adrenal Protection: Draw baseline serum cortisol levels, then immediately administer Hydrocortisone (100 mg IV) to cover potential concomitant adrenal insufficiency.
- Thyroid Hormone Replacement: Load with Levothyroxine (T4) 200–400 mcg IV slowly, followed by daily maintenance dosing of 50–100 mcg.
- T3 Supplementation: Consider adding Liothyronine (T3) 5–20 mcg IV loading in cases of profound neurological depression or severe cardiovascular collapse.
- Thermoregulation: Implement gentle rewarming interventions; avoid rapid physical warming, which can precipitate profound vasodilation and cardiovascular collapse.
- Fluid Stewardship: Exercise caution with IV fluid volume administration to prevent the exacerbation of severe hyponatremia and pulmonary edema.
Adrenal Crisis Protocol
Acute Adrenal Insufficiency Glucocorticoid Replacement Mapping.
- Diagnostic Sampling: Obtain urgent serum cortisol and ACTH levels, but do not delay therapeutic initiation while waiting for results.
- Glucocorticoid Replacement: Administer a bolus of Hydrocortisone (100 mg IV) immediately to provide rapid dual mineralocorticoid and glucocorticoid replacement.
- Volume & Metabolic Resuscitation: Infuse 1–2 liters of D5NS (5% Dextrose in Normal Saline) rapidly to correct severe hypotension, hypoglycemia, and hyponatremia.
- Continuous Dosing: Maintain Hydrocortisone therapy at 200 mg per 24 hours, administered via divided IV boluses or continuous infusion.
- Trigger Identification: Search for and aggressively treat precipitating stressors, such as infection/sepsis, surgery, trauma, or abrupt withdrawal of long-term corticosteroid therapy.
- Transitioning: Taper to oral maintenance corticosteroid dosing regimens only after hemodynamic stability has been fully achieved.
Infectious Disease / Sepsis
Sepsis Screening and Early Recognition Protocol
Bedside Clinical Hypoperfusion Identification Mapping.
- Screening Tools: Utilize systematic screening for all admissions using SIRS, qSOFA, or NEWS (National Early Warning Score) criteria.
- qSOFA Trigger: Initiate a formal sepsis evaluation if the qSOFA score is ≥ 2 (Criteria: Altered mental status, Respiratory Rate ≥ 22 breaths/min, Systolic Blood Pressure ≤ 100 mmHg).
- Biochemical Assessment: Measure serum lactate level and perform a physical exam to identify the likely infectious source.
- Team Activation: Notify the clinical response team immediately if systemic inflammatory markers align with suspected source tracking.
- Resuscitation Access: Establish large-bore peripheral intravenous access for rapid fluid resuscitation and initiate continuous vital sign monitoring.
- Diagnostic Proactivity: Order comprehensive blood/site cultures and diagnostic imaging prior to the onset of overt end-organ dysfunction.
Sepsis 1-Hour Bundle
Hyper-acute Severe Sepsis Intervention Checklist Mapping.
- Lactate Assessment: Measure initial serum lactate; re-measure if initial values are ≥ 2 mmol/L to gauge perfusion status.
- Microbiological Cultures: Obtain at least two sets of blood cultures prior to the administration of any antimicrobial therapies.
- Empiric Antimicrobials: Initiate targeted broad-spectrum antibiotics tailored to the suspected anatomical source (e.g., pneumonia, UTI, intra-abdominal).
- Fluid Resuscitation: Administer 30 mL/kg of balanced crystalloids for hypotension (MAP < 65 mmHg) or serum lactate ≥ 4 mmol/L.
- Vasopressor Support: Apply vasopressors (Norepinephrine is the first-line agent) if the patient remains hypotensive during or after fluid resuscitation to maintain MAP ≥ 65 mmHg.
- Reassessment: Continuously document volume status and tissue perfusion responses throughout the initial hour to guide ongoing care.
ICU Sepsis Source Control Protocol
Anatomical Infectious Nexus Eradication Mapping.
- Anatomical Identification: Identify the definitive location of infection via rapid imaging modalities (e.g., CT, US) within 12 hours of sepsis recognition.
- Subspecialty Coordination: Consult surgical or interventional teams early for rapid debridement, drainage, or resection options.
- Device Removal: Immediately remove or replace indwelling medical devices (central lines, urinary catheters, etc.) suspected of being the primary source or colonized reservoir.
- Urgent Interventions: Execute definitive procedures, such as percutaneous abscess drainage, surgical laparotomy, or wound debridement, to eliminate the infectious nidus.
- Antimicrobial Optimization: Ensure therapeutic antimicrobial tissue concentrations are maintained throughout all peri-procedural and surgical manipulation phases.
- Efficacy Monitoring: Re-evaluate source control adequacy if clinical signs or inflammatory markers (e.g., CRP, procalcitonin) fail to show down-titration within 48 hours.
Antibiotic Stewardship / De-escalation Protocol
Antimicrobial Rationalization & Culture Monotherapy Mapping.
- 48–72 Hour Review: Perform a mandatory formal antimicrobial review at the 48–72 hour mark post-admission (the "antibiotic time-out").
- Microbiological Analysis: Review all available blood, site, and sputum culture data alongside antibiotic susceptibility profiles (antibiograms).
- De-escalation: Transition from empiric, broad-spectrum combination therapies to the most narrow-spectrum agent that covers the identified pathogen.
- Targeted Therapy: Discontinue broad coverage (e.g., anti-MRSA or anti-pseudomonal agents) if culture and sensitivity results exclude these pathogens.
- IV-to-PO Conversion: Convert to oral antibiotic formulations as soon as clinical stabilization is achieved and gastrointestinal absorption is verified.
- Defined Duration: Establish and document a clear, definitive treatment duration to prevent prolonged therapy and the development of multidrug-resistant organisms (MDROs).
Severe Community-Acquired Pneumonia Protocol
Pneumonic Respiratory Failure Guideline Mapping.
- Severity Stratification: Utilize formal scoring systems such as CURB-65 or the Pneumonia Severity Index (PSI) to determine site of care and intensity of intervention.
- Empiric Combination Therapy: Administer beta-lactam (e.g., Ceftriaxone 1–2g IV) plus a macrolide (e.g., Azithromycin 500mg IV) daily.
- Alternative Regimen: For patients with severe penicillin allergies, administer a respiratory fluoroquinolone (e.g., Levofloxacin 750mg IV).
- Diagnostic Workup: Obtain sputum Gram stain/culture, urinary antigen tests for *Legionella* and *Streptococcus pneumoniae*, and blood cultures to guide de-escalation.
- Respiratory Support: Monitor gas exchange indices (e.g., SpO2, arterial blood gases) continuously; implement high-flow nasal cannula or non-invasive ventilation (NIV) as necessary.
- Risk-Based Escalation: Add coverage for MRSA (e.g., Vancomycin or Linezolid) or *Pseudomonas aeruginosa* (e.g., Piperacillin-Tazobactam or Cefepime) if there are documented prior exposures or specific structural lung diseases.
Ventilator-Associated Pneumonia (VAP) Bundle
Nosocomial Intubation Pneumonia Preventative Care Mapping.
- Positioning: Maintain the head of the bed (HOB) elevated between 30° and 45° to minimize the risk of micro-aspiration of oropharyngeal secretions.
- Sedation Strategy: Conduct daily "sedation vacations" and evaluate readiness for Spontaneous Breathing Trials (SBTs) to reduce time on mechanical ventilation.
- Secretions Management: Perform routine subglottic suctioning using dedicated suction-port endotracheal tubes to prevent pooling above the cuff.
- Oral Hygiene: Provide comprehensive oral care with 0.12% Chlorhexidine gluconate solutions every 6 hours to reduce the oral bacterial load.
- Circuit Maintenance: Empty ventilator circuit condensation accumulation regularly, ensuring it drains away from the patient and does not flow into the airway.
- Extubation: Prioritize early liberation from mechanical ventilation as soon as clinical parameters safely allow.
CLABSI Prevention Bundle
Central Line Vascular Insertion & Maintenance Mapping.
- Hand Hygiene: Mandate strict hand hygiene compliance prior to any central venous catheter (CVC) insertion or manipulation.
- Sterile Barrier: Enforce maximal sterile barrier precautions during insertion, including the use of head-to-toe drapes, gowns, masks, and sterile gloves.
- Skin Antisepsis: Prepare the insertion site using 2% Chlorhexidine gluconate, utilizing back-and-forth friction to ensure adequate antiseptic penetration.
- Site Selection: Avoid femoral vein access whenever possible, as this site is associated with significantly higher baseline bacterial colonization and infection rates.
- Site Dressing: Secure the catheter and apply a sterile, transparent, semi-permeable dressing to provide an occlusive barrier against external pathogens.
- Daily Audit: Conduct mandatory daily audits of line necessity and facilitate prompt removal of any CVC that is no longer clinically indicated.
CAUTI Prevention Bundle
Urinary Catheter Device Restrictive Maintenance Mapping.
- Appropriate Indication: Restrict indwelling urinary catheter (IUC) placement to well-defined clinical indications (e.g., urinary retention, accurate output monitoring in critically ill patients, urologic surgery).
- Aseptic Technique: Perform insertion using strict aseptic technique and sterile, single-use equipment.
- System Integrity: Maintain a closed drainage system at all times. Secure the catheter to the patient’s thigh to prevent urethral trauma and tension.
- Gravity Drainage: Keep the collection bag positioned continuously below the level of the bladder to facilitate gravity drainage and prevent urine reflux into the bladder.
- Perineal Hygiene: Perform routine daily perineal care using standard soap and water; avoid unnecessary meatal cleaning with harsh antiseptics.
- Daily Audit: Review the necessity of the catheter daily; prioritize prompt removal as soon as the clinical indication for its presence is resolved.
Renal / ICU System Protocols
Acute Kidney Injury (AKI) KDIGO Protocol
Renal Insult Classification & Injury Mitigation Mapping.
- Staging: Categorize AKI using the KDIGO criteria (based on dynamic serum creatinine increases and hourly urine output decrements).
- Nephrotoxin Mitigation: Immediately discontinue or adjust potentially nephrotoxic medications (e.g., NSAIDs, Aminoglycosides, ACE inhibitors/ARBs, Radiocontrast).
- Perfusion Optimization: Optimize systemic hemodynamic status to ensure adequate Mean Arterial Pressure (MAP) and renal perfusion.
- Obstruction Exclusion: Order renal ultrasound imaging to rule out post-renal (obstructive) etiologies for acute renal dysfunction.
- Pharmacotherapy Adjustment: Adjust dosing schedules of all maintenance medications based on estimated glomerular filtration rate (eGFR) and current clearance metrics.
- Metabolic Monitoring: Monitor electrolyte trends (specifically potassium, phosphate), net fluid balance, and acid-base status every 6–12 hours.
Continuous Renal Replacement Therapy (CRRT) Initiation Protocol
Extracorporeal Hemofiltration Indication & Setup Mapping.
- Indications (AEIOU): Evaluate for urgent initiation based on Refractory **A**cidosis, **E**lectrolyte extremes (e.g., hyperkalemia), **I**ntoxication (dialyzable toxins), **O**verload (refractory volume), and **U**remia (e.g., pericarditis, encephalopathy).
- Vascular Access: Establish large-bore, dual-lumen temporary dialysis catheter access in a central vein (IJ, Subclavian, or Femoral).
- Operational Mode: Select the mode based on clearance goals: CVVH (convection-based) or CVVHD (diffusion-based).
- Flow Configuration: Program initial parameters: blood flow 150–200 mL/min and replacement/dialysate fluids at 20–25 mL/kg/hr.
- Anticoagulation: Implement regional Citrate anticoagulation to maximize circuit life; perform serial monitoring of systemic and post-filter ionized calcium levels.
- Fluid Management: Titrate hourly net fluid removal targets based on real-time hemodynamic tolerance and volume status goals.
Electrolyte Replacement Protocol
Critical Electrolyte Sliding Scale Correction Mapping.
- Monitoring: Review daily serum chemistry values to initiate standardized, protocol-driven repletion.
- Potassium (K+): If 3.5–3.9 mEq/L, administer 40 mEq PO or 20 mEq IV (infuse slowly over 2 hours).
- Magnesium (Mg2+): If 1.5–1.9 mg/dL, infuse 2 grams of Magnesium Sulfate IV over 1 hour.
- Calcium (Ca2+): If ionized calcium is < 1.1 mmol/L, administer 1 gram of Calcium Gluconate IV.
- Synergistic Correction: Enforce simultaneous correction of hypomagnesemia to facilitate effective intracellular potassium recovery.
- Follow-up: Recheck serum electrolyte levels 2 hours after completing replacement infusions to document stability and avoid over-correction.
Fluid Resuscitation and Balance Protocol
Dynamic Volume Responsiveness Assessment Mapping.
- Monitoring: Document total fluid intake and output hourly to calculate and track net cumulative fluid balances.
- Dynamic Assessment: Assess fluid responsiveness utilizing dynamic indices: perform Passive Leg Raise (PLR) tests or evaluate Stroke Volume Variation (SVV) if the patient is mechanically ventilated.
- Fluid Choice: Utilize balanced crystalloid formulations (e.g., Lactated Ringer’s or Plasma-Lyte) to minimize the risk of hyperchloremic metabolic acidosis associated with excessive normal saline.
- Avoid Static Indices: Avoid relying solely on static Central Venous Pressure (CVP) values as indicators for fluid administration; they are poor predictors of fluid responsiveness.
- De-escalation: Transition to conservative fluid management or initiate diuretics once markers of end-organ perfusion stabilize.
- Congestion Screening: Systematically screen for signs of tissue congestion (the "VENOUS" clinical assessment): check for peripheral edema, ascites, and pulmonary rales.
ICU Glycemic Control Protocol
Critical Care Continuous Insulin Titration Mapping.
- Initiation: Begin a continuous intravenous Regular Insulin infusion if blood glucose levels consistently exceed 180 mg/dL.
- Frequency: Perform capillary or arterial point-of-care (POC) glucose checks every hour during the initiation and titration phases.
- Titration: Adjust the insulin infusion rate using a standardized, institutional-approved algorithm to safely achieve and maintain the target range of 140–180 mg/dL.
- Stability: Reduce the frequency of glucose checks to every 2 hours once blood glucose values remain stable within the target range for a specified period.
- Hypoglycemia Protocol: Stop the insulin infusion immediately and administer 50% Dextrose (D50W) if glucose drops below 70 mg/dL.
- Substrate Support: Ensure an ongoing, reliable source of carbohydrates (e.g., continuous enteral feeds or IV dextrose) to prevent recurrent hypoglycemia.
Stress Ulcer Prophylaxis Protocol
Gastrointestinal Mucosal Injury Prevention Mapping.
- Risk Screening: Systematically screen all ICU admissions for risk factors associated with stress-related mucosal disease (SRMD).
- High-Risk Indications: Limit prophylaxis to patients with definitive indications, primarily: mechanical ventilation requirements > 48 hours or clinically significant coagulopathy.
- Pharmacotherapy: Administer either Histamine-2 Receptor Antagonists (e.g., Famotidine 20mg IV/PO q12h) or Proton Pump Inhibitors (PPIs) based on institutional guidelines.
- Daily Review: Re-evaluate the indication for prophylaxis daily during multidisciplinary rounds to ensure therapy is still warranted.
- Discontinuation: Discontinue acid-suppressive therapy immediately once the patient is no longer high-risk and tolerates regular enteral nutritional feeds.
- Complication Monitoring: Actively monitor for potential side effects, including increased susceptibility to Clostridioides difficile and hospital-acquired pneumonia.
VTE Prophylaxis Protocol
Venous Thromboembolism Prophylactic Optimization Mapping.
- Risk Assessment: Assess baseline thromboembolic risk and bleeding risk profiles for all patients within 24 hours of admission.
- Pharmacological Prophylaxis: Administer standard dosing (e.g., Enoxaparin 40 mg SC daily or Unfractionated Heparin 5000 units SC q8h) in the absence of contraindications.
- Mechanical Prophylaxis: Apply Sequential Compression Devices (SCDs) for patients with high bleeding risks or as an adjunct to pharmacological therapy.
- HIT Monitoring: Monitor platelet trends every 2–3 days to screen for potential Heparin-Induced Thrombocytopenia (HIT).
- Compliance Documentation: Document mechanical compression sleeve application and patient compliance during every nursing shift.
- Discharge Transition: Transition patients to early ambulation or appropriate home anticoagulation plans upon discharge.
ICU Nutrition Support Protocol
Critical Care Nutritional Optimization Mapping.
- Risk Screening: Complete a formal nutritional risk screening (e.g., NUTRIC score) within 48 hours of ICU admission to identify high-risk patients.
- Enteral Priority: Prioritize early Enteral Nutrition (EN) over parenteral alternatives to preserve gut mucosal integrity and barrier function.
- Trophic Initiation: Initiate EN at trophic rates (10–20 mL/hr) within 24–48 hours of admission once the patient is hemodynamically stable.
- Caloric Advancement: Gradually advance infusion rates over 48–72 hours to achieve full caloric and protein requirements as tolerated.
- Residual Volumes: Avoid routine monitoring of Gastric Residual Volumes (GRVs); only assess if clinical signs of feeding intolerance or overt vomiting develop.
- Parenteral Backup: Consider Total Parenteral Nutrition (TPN) only if enteral routes remain completely contraindicated or insufficient for > 7 days.
Anesthesia Core Protocols
Preoperative Assessment Protocol
Surgical Risk Stratification & Pre-Anesthetic Optimization Mapping.
- History Review: Perform a comprehensive review of medical history, current home medications, and any history of adverse anesthetic events or family complications.
- Airway Assessment: Systematically evaluate airway features, including Mallampati classification, thyromental distance, and cervical range of motion (ROM).
- ASA Classification: Assign a definitive ASA Physical Status Classification score (I–VI) to reflect the patient's baseline health risk.
- NPO Verification: Verify adherence to standardized fasting guidelines (e.g., 8h for fatty meals/meat, 6h for light meals, 2h for clear liquids).
- Targeted Diagnostics: Order laboratory or imaging tests only when clinically indicated by comorbidities and the surgical complexity scale.
- Anesthesia Planning: Formulate an explicit anesthetic plan and ensure detailed informed consent is obtained, covering risks, benefits, and alternatives.
Standard Intraoperative Monitoring Protocol
ASA Physiological Guardrail Parameter Mapping.
- Baseline Monitoring: Apply and verify non-invasive blood pressure (NIBP), 3- or 5-lead ECG, and pulse oximetry (SpO2) interfaces.
- Oxygenation: Continuously evaluate oxygenation via SpO2, utilizing both the digital readout and audible pulse tones/plethysmographic waveforms.
- Ventilation: Monitor ventilation integrity using continuous quantitative waveform capnography (EtCO2) for all patients undergoing general anesthesia.
- Thermoregulation: Measure and track core temperature throughout all operative cases lasting longer than 30 minutes to prevent hypothermia.
- Circulation: Maintain consistent circulatory surveillance by obtaining blood pressure measurements at minimum intervals of every 5 minutes.
- Alarm Management: Ensure all physiological monitor alarm limits are active, audible, and appropriately configured for the patient's age and clinical status prior to induction.
Rapid Sequence Induction (Anesthesia Version)
Surgical Aspiration Risk Induction Mapping.
- Preparation: Confirm full readiness of high-suction systems and ensure all specialized airway equipment (e.g., laryngoscope, stylet, backup ETT) is tested and immediately accessible.
- Pre-oxygenation: Utilize high-flow, tight-fitting mask interfaces to achieve maximal denitrogenation of the functional residual capacity (FRC).
- Cricoid Pressure: Apply precise cricoid pressure (Sellick maneuver) to the cricoid cartilage prior to the loss of consciousness, if clinically indicated.
- Pharmacological Sequence: Administer induction agents and rapid-onset paralytics (e.g., Succinylcholine or high-dose Rocuronium) in immediate succession.
- Avoid Insufflation: Strictly avoid positive-pressure mask ventilation prior to cuff inflation to prevent gastric insufflation, which precipitates regurgitation.
- Definitive Airway: Perform laryngoscopy and secure the endotracheal tube; inflate the cuff fully to seal the airway before releasing cricoid pressure.
General Anesthesia Induction & Maintenance Protocol
Balanced Surgical Anesthetic State Management Mapping.
- Induction: Administer titrated IV co-agents (e.g., Fentanyl, Midazolam) followed by an induction bolus of Propofol (1.5–2.5 mg/kg) tailored to hemodynamic status.
- Airway Assessment: Confirm the patient's capacity for easy mask ventilation before proceeding to the administration of neuromuscular blocking agents.
- Airway Management: Secure the airway (ETT or LMA) and adjust mechanical ventilation parameters (e.g., lung-protective ventilation: 6–8 mL/kg ideal body weight) to protect lung integrity.
- Anesthetic Maintenance: Maintain stable anesthetic planes using either volatile inhalational agents or Total Intravenous Anesthesia (TIVA) with Propofol infusions.
- Depth Monitoring: Monitor Minimum Alveolar Concentration (MAC) fractions, maintaining values typically between 0.7–1.3 to ensure adequate suppression of response to surgical stimulus.
- Dynamic Titration: Titrate analgesics (e.g., opioids, regional blocks) and fluid volumes dynamically based on changing levels of surgical stimulation and hemodynamic response.
Total Intravenous Anesthesia (TIVA) Protocol
Volatile-Free Target-Controlled Infusion Mapping.
- IV Integrity: Establish secure, large-bore intravenous access and verify infusion line visibility and patency throughout the procedure.
- Pump Preparation: Prepare automated infusion pumps (or TCI devices) with appropriate Propofol and opioid (Remifentanil or Fentanyl) profiles.
- Induction & Maintenance: Deliver a Propofol loading dose followed by a continuous infusion (typically 100–150 mcg/kg/min for maintenance).
- Analgesic Titration: Titrate concurrent Remifentanil infusions (0.1–0.5 mcg/kg/min) to achieve stable hemodynamic control in response to surgical stimulation.
- Depth Monitoring: Utilize processed EEG monitoring (e.g., BIS or SedLine) to track brain activity, targeting a depth index value between 40–60.
- System Safety: Flush infusion lines carefully at the conclusion of the case to prevent delayed accidental drug boluses upon disconnection.
Regional Anesthesia Safety Protocol
Regional Neural Blockade Complication Mitigation Mapping.
- Verification: Confirm correct patient identity, the intended block procedure, and the surgically marked site.
- Safety Time-Out: Execute a formal pre-procedural safety time-out immediately prior to introducing any regional needle into the tissue.
- Monitoring: Apply standard ASA physiological monitors (ECG, NIBP, SpO2) and ensure supplemental oxygen is available.
- Asepsis: Prepare the injection site using sterile surgical prep kits and maintain strict aseptic technique to prevent infection.
- Aspiration Checks: Perform frequent negative aspiration checks for blood or CSF every 3–5 mL of local anesthetic (LA) injection.
- Systemic Surveillance: Maintain constant verbal contact with the patient during injection to monitor for early signs of Local Anesthetic Systemic Toxicity (LAST), such as metallic taste, circumoral numbness, or altered mental status.
Spinal Anesthesia Protocol
Subarachnoid Dense Dermatomal Blockade Mapping.
- Patient Positioning: Position the patient in a sitting or lateral decubitus configuration with the spine maximally flexed to widen interspinous spaces.
- Anatomic Landmark Identification: Identify the target interspace (L3-L4 or L4-L5) using anatomic landmarks under strictly sterile conditions.
- Subarachnoid Access: Introduce a fine-gauge spinal needle (e.g., pencil-point needle) until the dura is breached and clear Cerebrospinal Fluid (CSF) flow is visualized.
- Local Anesthetic Injection: Inject hyperbaric Bupivacaine 0.5% (typically 10–15 mg) slowly; confirm consistent CSF backflow to ensure subarachnoid placement.
- Block Progression: Return the patient to a supine position immediately post-injection and perform serial monitoring to track the dermatomal spread of the block.
- Hemodynamic Management: Proactively manage sympathectomy-induced hypotension using IV crystalloid boluses and vasopressors (e.g., Phenylephrine) to maintain systemic perfusion.
Epidural Anesthesia Protocol
Space Localization & Titratable Catheter Mapping.
- Positioning & Prep: Optimize patient positioning (sitting or lateral decubitus) and perform a comprehensive, sterile surgical skin preparation of the target lumbar or thoracic interspace.
- Needle Placement: Advance the Tuohy needle into the interspace, utilizing the "loss-of-resistance" (LOR) technique to air or saline to reliably identify the epidural space.
- Catheter Insertion: Thread the epidural catheter 3–5 cm into the epidural space, ensuring smooth advancement without resistance, then carefully withdraw the needle over the catheter.
- Test Dose: Administer a 3 mL local anesthetic test dose containing 1:200,000 Epinephrine to systematically rule out subarachnoid or intravascular placement.
- Safety Monitoring: Closely monitor for clinical indicators of misplacement, such as sudden tachycardia (suggesting intravascular injection) or an immediate, dense motor block (suggesting intrathecal injection).
- Final Stabilization: Secure the catheter with a sterile, occlusive adhesive dressing and initiate a titrated infusion to achieve the desired level of surgical anesthesia or labor analgesia.
Peripheral Nerve Block Protocol
Ultrasound-Guided Extremity Nerve Blockade Mapping.
- Positioning & Imaging: Properly position the target extremity and adjust ultrasound frequency/gain settings to optimize nerve bundle visualization.
- Asepsis: Maintain strict aseptic field preparation and utilize a sterile-sheathed ultrasound transducer to prevent procedural site infection.
- Needle Guidance: Advance the block needle in-plane under continuous, direct ultrasound visualization to ensure the path remains in the field of view.
- Placement: Confirm needle tip placement adjacent to—but not within—the nerve bundle. Avoid direct neural penetration to minimize trauma.
- Injection Dynamics: Aspirate carefully, then inject a 1–2 mL local anesthetic test volume to confirm and visualize proper circumferential spread.
- Completion: Deliver the calculated anesthetic volume while monitoring injection pressures to ensure they remain low throughout the process.
Neuromuscular Blockade Management Protocol
Intraoperative Paralytic Depth Objective Tracking Mapping.
- Setup: Apply peripheral nerve stimulation electrodes over the ulnar nerve (preferred for adductor pollicis monitoring) or facial nerve pathways.
- Baseline: Establish baseline stimulation metrics prior to administering any neuromuscular blocking agents (NMBAs) to ensure accurate future assessment.
- Objective Monitoring: Continuously monitor neuromuscular depth during the case using objective Train-of-Four (TOF) counts.
- Surgical Depth: Aim to maintain 1–2 twitches out of 4 (TOF 1/4 or 2/4) to provide adequate abdominal or thoracic muscle relaxation for optimal surgical exposure.
- Maintenance: Avoid empiric, "blind" administration of maintenance paralytics; only dose NMBAs when clear twitch recovery patterns are documented.
- Data Logging: Systematically log TOF values throughout the case to guide the timing and choice of safe pharmacological reversal agents.
Neuromuscular Reversal Protocol
Paralytic Clear Recovery Parameters Mapping.
- Assessment: Check quantitative Train-of-Four (TOF) metrics objectively before initiating any extubation sequence.
- Anticholinesterase Strategy: If TOF count is 2–4 twitches, administer Neostigmine (0.04–0.07 mg/kg) paired with an anticholinergic (Glycopyrrolate) to mitigate muscarinic side effects.
- Sugammadex (Standard): For Rocuronium or Vecuronium blocks with ≥ 2 TOF twitches, utilize Sugammadex 2 mg/kg.
- Sugammadex (Deep): Administer Sugammadex 4 mg/kg if deep blockade patterns are present (e.g., only post-tetanic counts detected).
- Objective Verification: Confirm return of strength by targeting an objective TOF ratio > 0.9.
- Clinical Correlation: Confirm clinical function, such as a sustained 5-second head lift and strong grip, only *after* the quantitative TOF ratio has reached the safety threshold.
Malignant Hyperthermia Emergency Protocol
Hypermetabolic Anesthetic Crisis Resuscitation Mapping.
- Recognition: Identify early triggers: unexplained hypercarbia (rising EtCO2), tachycardia, tachypnea, masseter muscle rigidity, and rapidly rising core temperature.
- Immediate Cessation: Discontinue all volatile anesthetic agents and Succinylcholine immediately. Call for the MH Cart/Emergency Assistance.
- Ventilation: Hyperventilate the circuit with 100% O2 at high flow rates (>10 L/min) to facilitate rapid clearance of CO2.
- Dantrolene Administration: Administer Dantrolene 2.5 mg/kg IV rapidly via a dedicated, large-bore intravenous line; repeat boluses as needed until hypermetabolic signs subside.
- Active Cooling: Initiate aggressive cooling measures: administer chilled IV saline (0.9% NaCl) and apply surface ice packs to axillary, groin, and cervical areas.
- Supportive Care: Monitor and manage electrolyte imbalances (specifically hyperkalemia) and acid-base disturbances (metabolic acidosis) in consultation with the ICU team.
Local Anesthetic Systemic Toxicity (LAST) Protocol
Intravascular Local Anesthetic Toxicity Rescue Mapping.
- Recognition: Identify early symptoms: perioral numbness, metallic taste, tinnitus, seizures, or sudden cardiac dysrhythmias (e.g., severe bradycardia, AV block).
- Immediate Intervention: Stop the local anesthetic injection immediately. Call for help and the specialized LAST rescue kit (Intralipid).
- Airway & Ventilation: Secure the airway and ventilate with 100% O2; aggressively prevent hypoxia and metabolic acidosis, which worsen local anesthetic cardiotoxicity.
- Lipid Bolus: Administer 20% Lipid Emulsion bolus (1.5 mL/kg) IV over 1 minute.
- Lipid Infusion: Initiate a continuous 20% Lipid Emulsion infusion at 0.25 mL/kg/min immediately following the bolus.
- Hemodynamic Support: Restrict standard Epinephrine doses to small increments (< 1 mcg/kg), as high-dose epinephrine may impair the efficacy of lipid resuscitation and worsen cardiac ischemia.
Postoperative Pain Management Protocol
Multimodal Post-Surgical Analgesia Optimization Mapping.
- Tailored Strategy: Review the specific surgical procedure to implement an evidence-based, multimodal analgesia framework tailored to patient needs.
- Non-Opioid Baseline: Schedule regular non-opioid baseline agents: Acetaminophen 1g (IV/PO) and NSAIDs (if no contraindications, such as renal dysfunction or bleeding risk, exist).
- Regional Adjuncts: Incorporate targeted local anesthetic wound infiltrations or continuous regional nerve block catheters to maximize site-specific pain control.
- PCA Configuration: Configure Patient-Controlled Analgesia (PCA) pumps with low-dose opioids primarily for severe, breakthrough pain management.
- Safety Limits: Set conservative demand limits on PCA systems and strictly avoid continuous background infusions (basal rates) in opioid-naïve patients to mitigate the risk of respiratory depression.
- Continuous Assessment: Reassess pain scores, sedation levels, and respiratory function regularly during the early postoperative recovery phases.
Postoperative Nausea and Vomiting (PONV) Protocol
Prophylactic Emetic Mitigation Risk Track Mapping.
- Risk Assessment: Compute individual PONV risk metrics using the Apfel score (history of PONV/motion sickness, female gender, non-smoker status, and expected opioid use).
- Low-Risk Strategy: Administer Dexamethasone 4–5 mg IV immediately after anesthesia induction for baseline prophylaxis.
- Moderate-Risk Strategy: Add Ondansetron 4 mg IV near the conclusion of the surgery to provide synergistic coverage.
- High-Risk Strategy: Combine a third agent from a different drug class (e.g., Haloperidol or Droperidol) to block multiple neuro-receptor emetic pathways.
- Anesthetic Modification: Maintain adequate hydration strategies and consider Total Intravenous Anesthesia (TIVA) with Propofol to minimize volatile anesthetic-induced emesis.
- Rescue Management: Utilize pharmacological agents from a different class than the initial prophylaxis for breakthrough emesis in the PACU.
PACU Recovery and Discharge Protocol
Post-Anesthetic Recovery Room Discharge Mapping.
- Clinical Handover: Receive a structured, formal clinical report from the anesthesia provider upon arrival in the Post-Anesthesia Care Unit (PACU).
- Continuous Monitoring: Monitor vital physiological parameters (BP, HR, SpO2, RR) at 5-minute intervals during the initial, high-acuity recovery phase.
- Recovery Scoring: Quantify recovery progression using standardized Aldrete scoring grids, evaluating activity, respiration, circulation, consciousness, and oxygen saturation.
- Stability Verification: Ensure stable respiratory patterns, sustained oxygenation targets, and preserved hemodynamic stability independent of vasoactive support.
- Surgical Surveillance: Confirm that postoperative pain metrics remain controlled and that surgical sites are intact with no evidence of active hemorrhage.
- Discharge Authorization: Formally authorize safe transfer to the inpatient ward only once the patient achieves an Aldrete score ≥ 9.
ICU Care Bundles / System Protocols
Sedation and Analgesia Protocol
Analgesia-First Intensive Care Sedation Mapping.
- Analgesia Prioritization: Assess pain formally and manage with scheduled non-opioids or continuous IV analgesia (e.g., Fentanyl) as the foundation of comfort.
- Analgesia-First Strategy: Ensure adequate pain control is established *before* initiating or escalating secondary sedative infusions.
- Sedative Selection: Utilize non-benzodiazepine agents, prioritizing Propofol or Dexmedetomidine to improve neurocognitive outcomes.
- Goal-Directed Care: Establish a clear sedation target using the Richmond Agitation-Sedation Scale (RASS) for every shift.
- Continuous Titration: Perform hourly titration of sedative infusions to maintain a light, calm, and collaborative RASS goal (0 to -1).
- Benzodiazepine Avoidance: Avoid continuous benzodiazepine infusions, which are strongly linked to prolonged mechanical ventilation and increased risk of ICU delirium.
ICU Delirium Prevention (ABCDEF Bundle)
Multicomponent Cognitive Preservation Bundle Mapping.
- A - Assess, Prevent, & Manage Pain: Utilize standardized, objective pain-scoring tools to guide analgesic titration.
- B - Both SAT & SBT: Coordinate daily Spontaneous Awakening Trials (SAT) and Spontaneous Breathing Trials (SBT) to facilitate liberation from sedation and ventilation.
- C - Choice of Sedation: Prioritize light sedation goals and select agents (Propofol/Dexmedetomidine) that minimize the risk of cognitive impairment.
- D - Delirium Assessment: Screen every shift for hyperactive and hypoactive delirium using validated tools like the CAM-ICU or the Intensive Care Delirium Screening Checklist (ICDSC).
- E - Early Mobility: Initiate physical and occupational therapy as early as patient stability permits to prevent ICU-acquired weakness.
- F - Family Engagement: Facilitate consistent family presence and normalize sleep-wake cycles to provide cognitive orientation and comfort.
Early Mobilization Protocol
Critical Care Progressive Physical Therapy Mapping.
- Daily Screening: Evaluate patients daily against safety criteria, including hemodynamic stability (e.g., stable vasopressor requirements) and respiratory reserve.
- Basic Maintenance: Initiate passive range-of-motion (ROM) exercises and frequent repositioning for immobilized patients to prevent pressure injuries.
- Progressive Engagement: Advance to active-assisted movements and bedside sitting positions as clinical tolerance allows.
- Postural Development: Transition to standing exercises and assisted chair transfers once postural stability and core strength are achieved.
- Ambulation: Facilitate progressive ambulation trials within the ICU room while maintaining continuous monitoring of hemodynamics and ECG.
- Safety Terminations: Terminate mobility sessions immediately if heart rate shifts > 20% from baseline, oxygen saturation drops, or symptomatic hypotension develops.
Ventilator Bundle (VAP Prevention)
Intubated Ventilatory Complication Prevention Mapping.
- Head of Bed Elevation: Maintain head-of-bed elevation between 30° and 45° to minimize the risk of oropharyngeal micro-aspiration into the lower airway.
- Liberation Planning: Perform daily sedation holidays and Spontaneous Breathing Trials (SBTs) to identify the earliest possible opportunity for extubation.
- Stress Ulcer Prophylaxis: Administer prophylaxis (H2 blockers or PPIs) selectively, limiting use to patients meeting strict high-risk criteria for stress-related mucosal disease.
- VTE Prophylaxis: Ensure initiation of daily venous thromboembolism (VTE) prophylaxis using appropriate pharmacological (e.g., LMWH) or mechanical (SCD) methods.
- Oral Hygiene: Perform comprehensive oral care using Chlorhexidine (0.12%) every 6–8 hours to inhibit the formation of dental plaque and reduce oropharyngeal bacterial colonization.
- Circuit Management: Drain ventilator circuit condensate frequently and maintain a closed-circuit system to prevent bacterial ingress.
Central Line Bundle (CLABSI Prevention)
Central Venous Catheter Infection Risk Mitigation Mapping.
- Hand Hygiene: Enforce strict hand hygiene protocols immediately before any line insertion or procedural manipulation.
- Sterile Barriers: Utilize maximal sterile barrier precautions during insertion, including sterile gown, gloves, cap, mask, and full-body drape.
- Skin Antisepsis: Prep insertion sites using 2% Chlorhexidine gluconate with friction mechanics; allow to air dry completely before proceeding.
- Site Selection: Avoid femoral insertion sites in adults whenever possible to minimize the high bacterial colonization risks associated with the groin.
- Line Necessity: Perform a daily review of line utility metrics; promptly remove central venous catheters that are no longer clinically essential.
- Access Hygiene: Disinfect all injection ports ("scrub the hub") with 70% alcohol or chlorhexidine wipes for at least 15 seconds before every access.
Urinary Catheter Bundle (CAUTI Prevention)
Indwelling Catheter Device Optimization Mapping.
- Appropriate Indication: Restrict indwelling catheter placement strictly to defined clinical indications (e.g., precise hemodynamic monitoring in shock, acute urinary retention, or complex surgical necessity).
- Aseptic Insertion: Ensure device insertion is performed using strict aseptic techniques and standardized sterile equipment sets.
- Closed System Integrity: Maintain a completely uninterrupted closed drainage system; avoid breaking the seal for routine urine sampling or irrigation.
- Positioning: Secure collection bags continuously below the level of the bladder to facilitate gravity drainage and prevent retrograde reflux.
- Perineal Hygiene: Conduct daily perineal hygiene assessments using mild soap and water to minimize the local bacterial burden.
- Prompt Removal: Discontinue urinary catheters immediately when accurate hourly output tracking or bladder decompression is no longer clinically mandated.
ICU Liberation Bundle
Critical Care Sedation & Ventilator Weaning Integration Mapping.
- SAT-SBT Coordination: Pair Spontaneous Awakening Trials (SAT) directly with Spontaneous Breathing Trials (SBT) to break the "sedation-ventilation" lock.
- Sedation Interruption: Discontinue continuous sedative infusions daily to objectively evaluate neurological responsiveness and intrinsic respiratory drive.
- Breathing Trial: Perform a formal Spontaneous Breathing Trial (SBT) immediately if the patient successfully tolerates the awakening window.
- Delirium Surveillance: Screen for delirium development every shift using validated metrics like the CAM-ICU or the Intensive Care Delirium Screening Checklist (ICDSC).
- Early Mobilization: Initiate physical therapy and mobility exercises as soon as the patient meets weaning safety parameters.
- Family Engagement: Actively involve family in the recovery process to provide cognitive orientation, reduce anxiety, and promote a normal sleep-wake cycle.
End-of-Life Care / Withdrawal of Support Protocol
Compassionate Comfort Care & Palliation Mapping.
- Goals of Care: Confirm consensus regarding the transition to comfort-focused goals through detailed, sensitive multidisciplinary family meetings.
- De-escalation of Care: Discontinue non-essential monitoring (e.g., telemetry, pulse oximetry), routine laboratory draws, and diagnostic imaging.
- Systematic Withdrawal: Withdraw life-sustaining interventions—including vasopressors, blood products, and renal replacement therapy—in a phased, compassionate manner.
- Symptom Management: Titrate continuous opioid and benzodiazepine infusions to effectively eliminate signs of air hunger, respiratory distress, and physical pain.
- Ventilatory Support: Adjust ventilator settings for maximum comfort or perform planned terminal extubation, strictly following the patient’s advance directives and family preferences.
- Support Services: Provide dedicated emotional, psychological, and spiritual support services to the patient and family throughout the transition.
Trauma / Surgical Emergencies
Trauma Primary Survey
Life-Threatening Injury Rapid Identification Mapping.
- A - Airway: Establish and maintain airway patency while concurrently applying rigid manual cervical spine stabilization.
- B - Breathing: Evaluate ventilation mechanics; identify and immediately treat life-threatening thoracic injuries (e.g., tension pneumothorax) via needle or finger decompression.
- C - Circulation: Assess perfusion markers; establish two large-bore IV access points, initiate volume resuscitation, and utilize direct pressure or tourniquets to control external hemorrhage.
- D - Disability: Perform a rapid neurologic assessment using the Glasgow Coma Scale (GCS) and pupil reactivity to identify potential intracranial emergencies.
- E - Exposure: Fully expose the patient to facilitate a thorough trauma evaluation; prioritize forced-air warming to aggressively mitigate the "lethal triad" of trauma (hypothermia, coagulopathy, and acidosis).
- Immediate Correction: Manage life-threatening physiological impairments immediately upon detection; do not progress to the secondary survey until "ABCDE" stability is achieved.
Trauma Secondary Survey
Comprehensive Head-to-Toe Injury Mapping.
- Timing: Initiate the secondary survey only after the primary survey is complete and the patient is hemodynamically stable.
- AMPLE History: Systematically collect information: Allergies, Medications, Past medical history, Last meal, and Events/Environment surrounding the injury.
- Head-to-Toe Exam: Perform a meticulous, systematic evaluation of every anatomical region, including the head, face, neck, chest, abdomen, pelvis, perineum, extremities, and back.
- Log-Roll: Execute a log-roll maneuver as a single unit with dedicated manual cervical spine stabilization to inspect the entire posterior spine and paraspinal musculature.
- Pelvic Assessment: Assess pelvic stability once using a single, gentle compression; strictly avoid repeated testing to prevent the disruption of formed clots and worsening of hemorrhage.
- Diagnostic Imaging: Order indicated diagnostics (e.g., eFAST, pan-scan CT, or targeted plain films) driven by the specific mechanism of injury and physical exam findings.
Chest Tube Insertion Protocol
Surgical Tube Thoracostomy Maneuver Mapping.
- Positioning & Site: Place the patient supine or semi-recumbent with the ipsilateral arm abducted. Identify the "triangle of safety" (4th or 5th intercostal space at the mid-axillary line).
- Anesthesia & Prep: Utilize full sterile technique; infiltrate local anesthetic thoroughly, extending from the skin down through the periosteum to the pleura.
- Dissection: Create a 2–3 cm skin incision and perform careful blunt dissection through the subcutaneous tissues and intercostal muscles, staying strictly superior to the rib.
- Pleural Access: Puncture the parietal pleura using a clamped forceps, followed by careful digital exploration of the pleural space to confirm lack of adhesions.
- Tube Placement: Advance the chest tube posteriorly and superiorly toward the apex of the pleural space, ensuring the last fenestration is inside the thoracic cavity.
- Stabilization & Confirmation: Secure the tube with sutures, connect it to a water-seal drainage system (e.g., Pleur-evac), and obtain a confirmatory chest X-ray.
Tension Pneumothorax Decompression Protocol
Emergent Obstructive Shock Alleviation Mapping.
- Clinical Recognition: Identify key markers: severe respiratory distress, unilateral absent breath sounds, jugular venous distention (JVD), tracheal deviation (late), and obstructive hypotension.
- Site Selection: Identify appropriate decompression sites: either the 2nd intercostal space at the midclavicular line or the 4th/5th intercostal space at the anterior axillary line.
- Decompression Technique: Insert a large-bore (10–14 gauge) angiocath needle directly over the superior border of the rib to avoid the intercostal neurovascular bundle.
- Verification: Remove the needle stylet upon pleural entry; listen for the distinct "hiss" or rush of air signaling decompression of the tension state.
- Temporary Management: Leave the catheter open to the atmosphere or attach a one-way flutter valve to maintain continuous decompression.
- Definitive Care: Transition immediately to the insertion of a definitive surgical chest tube (tube thoracostomy).
Burn Resuscitation Protocol
Thermal Injury Fluid Calculations Mapping.
- TBSA Estimation: Calculate the Total Burn Surface Area (TBSA) of partial-thickness and full-thickness burns using the Rule of Nines or the Lund-Browder chart.
- Parkland Formula: Calculate the total 24-hour crystalloid requirement: 4 mL × weight (kg) × % TBSA.
- Fluid Selection: Prioritize Lactated Ringer’s solution for resuscitation to reduce the risk of hyperchloremic metabolic acidosis.
- Phase 1 Resuscitation: Administer 50% of the calculated total volume within the first 8 hours post-injury.
- Phase 2 Resuscitation: Infuse the remaining 50% of the calculated volume over the subsequent 16 hours.
- Output Monitoring: Titrate fluid rates based on objective hourly urine output; target 0.5 to 1 mL/kg/hr in adults to confirm adequate end-organ perfusion.
Acute Abdomen / Surgical Emergency Protocol
Peritonitis & Visceral Perforation Evaluation Mapping.
- Initial Stabilization: Establish strict NPO status and initiate empiric broad-spectrum IV antibiotics immediately to cover likely enteric flora.
- Peritonitis Assessment: Carefully evaluate for clinical markers of peritonitis: involuntary guarding, board-like abdominal rigidity, and rebound tenderness.
- Imaging Strategy: Screen for hollow viscus perforation via upright chest X-ray (to visualize subdiaphragmatic pneumoperitoneum) or non-contrast CT abdomen/pelvis for higher diagnostic sensitivity.
- Volume Resuscitation: Administer isotonic crystalloids (e.g., Lactated Ringer’s) to maintain hemodynamic stability and restore effective circulating volume in the face of third-space fluid losses.
- Laboratory Profiling: Order CBC with differential, BMP, blood cultures, type and screen, and serum lactate levels to quantify the degree of septic physiology.
- Urgent Consultation: Secure an immediate general surgery consultation for formal evaluation and to coordinate potential emergent laparotomy or laparoscopic intervention.
GI Bleeding Emergency Protocol
Massive Gastrointestinal Hemorrhage Stabilization Mapping.
- Resuscitation & Access: Establish two large-bore (16–18g) IV lines; initiate aggressive fluid resuscitation and prepare type-specific blood products, maintaining a restrictive transfusion threshold (Hb < 7 g/dL) in stable patients.
- Airway Protection: Intubate early if hematemesis is massive, persistent, or creates a significant risk for pulmonary aspiration.
- Pharmacologic Stabilization (Ulcer): Initiate high-dose IV Proton Pump Inhibitor therapy (e.g., 80 mg Pantoprazole bolus + 8 mg/hr infusion) to optimize clot stability in peptic ulcer disease.
- Pharmacologic Stabilization (Variceal): Administer IV Octreotide (50 mcg bolus + 50 mcg/hr infusion) immediately for suspected variceal bleeding to reduce portal venous pressure.
- Infection Prophylaxis: Administer prophylactic broad-spectrum antibiotics (e.g., Ceftriaxone) in all cirrhotic patients to reduce mortality associated with spontaneous bacterial peritonitis.
- Definitive Management: Coordinate urgent endoscopic evaluation (EGD) or Interventional Radiology consultation for definitive source control via clipping, banding, or embolization.
Polytrauma Resuscitation Protocol
Severe Multi-System Injury Resuscitation Mapping.
- Damage Control Resuscitation (DCR): Shift clinical focus from definitive anatomical repair to aggressive physiological stabilization.
- Crystalloid Restriction: Strictly limit large-volume crystalloid infusions to prevent dilutional coagulopathy, metabolic acidosis, and the displacement of formed clots.
- Massive Transfusion Protocol (MTP): Initiate MTP early; maintain a balanced component ratio (e.g., 1:1:1 plasma-to-platelets-to-RBC) to mimic whole blood composition.
- The Lethal Triad: Proactively manage and reverse the "Lethal Triad" of trauma: Acidosis, Hypothermia, and Coagulopathy.
- Damage Control Surgery (DCS): Expedite transport to the operating room for rapid control of hemorrhage and contamination; defer extensive reconstruction.
- Definitive Reconstruction: Plan for definitive anatomical repair only *after* physiological homeostasis (normothermia, normal pH, and stable coagulation) is restored.
Toxicology / Environmental Emergencies
Opioid Overdose Protocol
Narcotic-Induced Respiratory Depression Rescue Mapping.
- Clinical Assessment: Confirm the opioid toxidrome: miosis, CNS depression, and—most crucially—depressed respiratory rate or apnea.
- Naloxone Administration: Administer cautious, low-dose Naloxone (0.04 to 0.4 mg IV, IM, or IN) to restore baseline respiratory drive.
- Ventilatory Support: Provide manual bag-valve-mask (BVM) ventilation as the primary intervention until the patient's spontaneous respirations are adequate.
- Titration Strategy: Titrate Naloxone incrementally to achieve ventilation without inducing acute opioid withdrawal (characterized by extreme agitation, emesis, and tachycardia).
- Observation Window: Maintain continuous monitoring for at least 4–6 hours post-administration to ensure the patient does not experience recurrent respiratory depression.
- Special Considerations: For ingestion of long-acting agents (e.g., Methadone, ER-Oxycodone), anticipate the need for extended observation or a continuous Naloxone infusion.
Benzodiazepine Overdose Protocol
Sedative-Hypnotic Ingestion Management Mapping.
- Airway & Breathing: Prioritize airway patency and provide assisted ventilation if respiratory depression is present.
- Monitoring: Maintain continuous cardiac telemetry and pulse oximetry for all patients presenting with significant sedative ingestion.
- Flumazenil Restriction: Avoid routine Flumazenil use in undifferentiated overdose, as it can precipitate refractory seizures.
- Selective Reversal: Limit Flumazenil administration strictly to specific, low-risk scenarios, such as monitored procedural sedation reversal or acute pediatric ingestions in opioid-naive patients.
- Co-Ingestion Screening: Aggressively screen for pro-convulsant co-ingestions (e.g., tricyclic antidepressants), as these agents significantly increase the seizure risk associated with benzodiazepine antagonism.
- Supportive Management: Utilize supportive, long-acting sedative titration only if the patient displays clinically significant signs of withdrawal secondary to chronic dependency.
Organophosphate Poisoning Protocol
Cholinergic Toxidrome & Acetylcholinesterase Reactivation Mapping.
- Provider Safety: Prioritize personal safety; don appropriate PPE and perform thorough, rapid dermal decontamination to prevent secondary caregiver exposure.
- Atropinization: Initiate Atropine (1–3 mg IV bolus) and double the dose every 3–5 minutes until the endpoint is achieved: the drying of pulmonary secretions.
- Antidote Therapy: Administer Pralidoxime (2-PAM) 1–2g IV over 20–30 minutes to facilitate acetylcholinesterase reactivation and combat nicotinic blockade.
- Continuous Maintenance: Transition to a Pralidoxime infusion (200–500 mg/hr) to maintain therapeutic levels and prevent neuromuscular re-curarization.
- Respiratory Support: Employ aggressive, frequent airway suctioning and provide mechanical ventilation as necessary to manage respiratory failure.
Toxic Alcohol Protocol
Methanol / Ethylene Glycol Competitive Blockade Mapping.
- Diagnostics: Calculate the osmolal gap and screen for a high anion gap metabolic acidosis (AGMA).
- ADH Inhibition: Administer Fomepizole (15 mg/kg IV load) immediately to competitively inhibit alcohol dehydrogenase (ADH) and halt the production of toxic metabolites.
- Alternative Strategy: In the absence of Fomepizole, initiate a continuous Ethanol infusion targeting a serum concentration of 100–150 mg/dL.
- pH Management: Use IV Sodium Bicarbonate supplementation if systemic arterial pH < 7.30 to favor ionized acid excretion.
- Metabolic Cofactors: Enhance non-toxic metabolic pathways: provide Thiamine and Pyridoxine (for Ethylene Glycol) or Folic Acid/Leucovorin (for Methanol).
- Definitive Care: Arrange urgent hemodialysis for severe complications: intractable acidosis (pH < 7.15), acute kidney injury, visual disturbances (Methanol), or end-organ damage.
Carbon Monoxide Poisoning Protocol
Tissue Hypoxia Carboxyhemoglobin Displacement Mapping.
- Source Control: Immediate removal of the patient from the exposure environment; prioritize rescuer safety to prevent secondary casualties.
- High-Flow Oxygen: Initiate 100% oxygen via a tight-fitting non-rebreather (NRB) mask or endotracheal tube immediately to maximize CO displacement.
- Diagnostic Verification: Utilize formal co-oximetry (from arterial or venous blood gas) to accurately quantify Carboxyhemoglobin (COHb) levels.
- Pharmacodynamics: Continue 100% oxygen therapy to reduce the COHb half-life from ~320 minutes (room air) to approximately 90 minutes.
- Risk Assessment: Screen for high-risk criteria: syncope, altered mental status, seizures, pregnancy, myocardial ischemia, or COHb levels > 25%.
- Hyperbaric Consultation: Coordinate urgent transfer for Hyperbaric Oxygen (HBO) therapy if high-risk neurological or cardiac indicators are identified.
Heat Stroke Protocol
Hyperthermic Neuro-Axial Crisis Resuscitation Mapping.
- Monitoring: Establish continuous core temperature monitoring via rectal probe and secure immediate large-bore IV access.
- Rapid Cooling: Initiate aggressive physical cooling; the gold standard is ice-water immersion, or continuous evaporative cooling (mist and fan) as a high-efficacy alternative.
- Pharmacologic Caveat: Avoid all antipyretics (Aspirin, Acetaminophen); these agents are ineffective in environmental hyperthermia and may exacerbate coagulopathy or hepatic injury.
- Hemodynamic Support: Administer chilled (4°C) isotonic crystalloid fluids to support systemic perfusion and aid in internal cooling.
- Shivering Suppression: Monitor for shivering; administer low-dose IV benzodiazepines if present to inhibit endogenous heat production.
- Cooling Termination: Discontinue active cooling measures promptly when the core temperature reaches 39°C to prevent iatrogenic overshoot hypothermia.
Hypothermia Management Protocol
Accidental Core Thermal Recovery & Stabilization Mapping.
- Staging Assessment: Utilize esophageal or rectal probes to determine core temperature (Mild: 32–35°C; Moderate: 28–32°C; Severe: <28°C).
- Passive Rewarming: For mild hypothermia, remove all wet clothing, insulate with dry blankets, and promote endogenous heat generation.
- Active External Rewarming: Apply forced-air warming blankets to the torso for moderate hypothermia to maximize heat transfer to the core.
- Active Internal Rewarming: For severe cases, initiate 42°C IV fluids and provide warmed, humidified oxygen via the ventilatory circuit.
- Arrhythmia Prevention: Minimize patient handling; the hypothermic myocardium is exquisitely irritable and prone to life-threatening ventricular fibrillation.
- Resuscitation Endpoint: Extend ACLS efforts; maintain aggressive rewarming, as physiological function is often restorable until the patient is "warm and dead" (typically >32°C).
Emergency Cases
Cardiac Emergencies
Acute Coronary Syndrome (ACS)
Ischemic Myocardial Insult & Early Antithrombotic Mapping.
- Diagnostics: Obtain and interpret a diagnostic 12-lead ECG within 10 minutes of clinical presentation.
- Antiplatelet Therapy: Administer 162 to 325 mg of non-enteric coated Aspirin immediately, instructing the patient to chew it.
- Access: Establish large-bore IV access and draw blood samples for high-sensitivity cardiac troponins.
- Nitroglycerin: Deliver sublingual Nitroglycerin 0.4 mg every 5 minutes (up to 3 doses) while monitoring for hypotension.
- Oxygenation: Administer supplemental oxygen only if oxygen saturation parameters drop strictly below 90%.
- Anticoagulation: Initiate systemic anticoagulation with Unfractionated Heparin or LMWH based on risk profiles.
ST-Elevation Myocardial Infarction (STEMI)
Hyper-acute Transmural Infarction Emergency Reperfusion Mapping.
- Identification: Identify ST-segment elevation elevations matching at least 1 mm in two or more contiguous leads.
- Activation: Activate the cardiac catheterization laboratory immediately via a single-call notification code.
- Time Targets: Maintain target door-to-balloon intervals strictly under 90 minutes for primary PCI tracks.
- Pharmacotherapy: Administer a loading dose of a P2Y12 inhibitor (Ticagrelor 180 mg or Clopidogrel 600 mg) without delay.
- Fibrinolysis: Formulate a fibrinolytic protocol (Alteplase or Tenecteplase) if PCI window limits exceed 120 minutes.
- Monitoring: Maintain continuous dysrhythmia monitoring, keeping defibrillation pads attached to the patient.
Non-ST Elevation Myocardial Infarction (NSTEMI)
Non-Transmural Ischemic Evaluation & Stratification Mapping.
- Diagnostics: Confirm myocardial injury patterns via positive serial high-sensitivity troponin biomarkers.
- ECG Analysis: Evaluate ischemic variations on ECG: search for dynamic ST-segment depressions or T-wave inversions.
- Risk Stratification: Compute formal clinical risk metrics utilizing TIMI or GRACE scoring calculators within 1 hour.
- Medical Optimization: Initiate foundational medical optimization: administer regular antiplatelets and therapeutic Heparin loops.
- Invasive Strategy: Plan early invasive angiography within 24 hours for high-risk configurations or refractory chest pain.
- Symptom Control: Add continuous IV Nitroglycerin infusions to control persistent, dynamic anginal symptoms.
Cardiac Arrest
Sudden Mechanistic Collapse & Global Resuscitation Mapping.
- Recognition: Verify pulselessness and immediate apnea parameters; call for a defibrillator system instantly.
- Compressions: Initiate high-quality chest compressions matching a rate of 100 to 120 per minute and a depth of 2 to 2.4 inches.
- Rhythm Assessment: Check rhythm morphology status at the 2-minute mark, minimizing absolute pauses to less than 10 seconds.
- Defibrillation & Meds: Shock instantly if rhythm is shockable (VF or pVT); follow with continuous CPR and Epinephrine 1 mg every 3 to 5 minutes.
- Antiarrhythmics: Administer Amiodarone 300 mg bolus or Lidocaine 1.5 mg/kg for refractory shockable loops.
- Airway & Monitoring: Establish a definitive advanced airway paired with continuous waveform capnography monitoring.
Ventricular Tachycardia (VT)
Monomorphic / Polymorphic Ventricular Tachyarrhythmia Mapping.
- Hemodynamic Assessment: Assess hemodynamic parameters rapidly: check for hypotension, altered sensorium, or chest pain.
- Unstable Management: If pulseless or unstable: execute immediate unsynchronized defibrillation (or synchronized cardioversion if unstable with a pulse).
- Stable Monomorphic VT: If stable monomorphic: infuse Amiodarone 150 mg over 10 minutes or Procainamide 20 to 50 mg per minute.
- Polymorphic/Torsades de Pointes: If polymorphic with prolonged QT (Torsades de Pointes): administer Magnesium Sulfate 1 to 2 grams IV over 15 minutes.
- Diagnostics: Obtain a 12-lead ECG to verify wide-complex morphology status and underlying causes.
- Electrolytes: Correct concurrent electrolyte shifts, aggressively targeting Potassium greater than 4.0 mEq/L and Magnesium greater than 2.0 mg/dL.
Ventricular Fibrillation (VF)
Chaotic Ventricular Disorganization & Defibrillation Mapping.
- Identification: Identify ventricular fibrillation waves instantly on the monitor screen configuration.
- Defibrillation: Deliver an immediate high-energy unsynchronized shock (200J biphasic or 360J monophasic).
- CPR: Resume continuous high-quality chest compressions immediately for 2 minutes without checking a pulse.
- Epinephrine: Administer Epinephrine 1 mg IV or IO during the second compression loop and repeat every 3 to 5 minutes.
- Antiarrhythmics: Deliver a second shock if VF persists, followed by Amiodarone 300 mg IV push after the third shock.
- Reversible Causes: Actively search for and reverse underlying precipitating causes via the H's and T's framework.
Supraventricular Tachycardia (SVT)
Paroxysmal Narrow-Complex Tachyarrhythmia Elimination Mapping.
- Hemodynamic Assessment: Assess stability: look for signs of altered sensorium, hypotension, or heart failure.
- Unstable Management: If unstable: proceed directly to immediate synchronized cardioversion (50 to 100 Joules initial settings).
- Vagal Maneuvers: If stable: instruct the patient to perform optimized vagal maneuvers (modified Valsalva technique).
- Adenosine (Initial): Administer Adenosine 6 mg rapid IV push through a large-bore proximal IV line if maneuvers fail.
- Flush Technique: Follow the adenosine bolus with an immediate 20 mL normal saline flush while running an ECG strip.
- Adenosine (Escalation): Escalate to Adenosine 12 mg IV if the tachyarrhythmia does not convert within 1 to 2 minutes.
Atrial Fibrillation with RVR
Irregular Tachydysrhythmia Rate & Rhythm Optimization Mapping.
- Hemodynamic Assessment: Evaluate for instability; perform urgent synchronized cardioversion if perfusion fails.
- Rate Control Strategy: If stable, select a primary rate control drug pathway using Beta-blockers or Diltiazem IV infusions.
- Beta-Blocker Dosing: Administer Metoprolol 5 mg slow IV push every 5 minutes up to a maximum dose of 15 mg.
- Calcium Channel Blocker Dosing: Alternatively, load Diltiazem 0.25 mg/kg IV over 2 minutes, followed by a continuous rate-titrated infusion.
- Risk Stratification: Assess the onset duration window; screen for thromboembolic risks prior to planning any rhythm conversion.
- Anticoagulation: Initiate systemic anticoagulation arrays using Heparin lines if the duration exceeds 48 hours.
Complete Heart Block / Bradyarrhythmias
High-Degree Atrioventricular Dissociation Stabilization Mapping.
- Identification: Identify total AV dissociation, Mobitz Type II patterns, or profound sinus bradycardia on ECG.
- Atropine Therapy: Administer Atropine 1 mg IV bolus every 3 to 5 minutes up to 3 mg as an initial, temporizing step.
- Transcutaneous Pacing (TCP): Transition instantly to TCP if Atropine fails or symptoms are severe.
- Capture Optimization: Adjust the pacemaker current output to achieve definitive electrical and mechanical pulse capture.
- Chronotropic Support: Initiate an alternative continuous chronotropic drug infusion: Dopamine or Epinephrine at 2 to 20 mcg per minute.
- Definitive Care: Secure an emergency cardiology consultation track for temporary transvenous pacing wire placement.
Cardiogenic Shock (Cardiac)
Primary Mechanical Pump Failure & Hypoperfusion Rescue Mapping.
- Hemodynamic Monitoring: Establish continuous intra-arterial line monitoring to measure mean arterial pressure profiles.
- Bedside Evaluation: Perform an emergency bedside echocardiogram to assess global left and right ventricular contractility.
- Fluid Management: Infuse crystalloid fluid boluses very cautiously in small (250 mL) increments if the lungs are completely clear.
- Vasopressor Support: Initiate Norepinephrine central infusions to support systemic vascular resistance and maintain mean arterial pressure at 65 mmHg or greater.
- Inotropic Support: Add positive inotropic support via Dobutamine 2 to 20 mcg/kg/min to increase forward stroke volume.
- Mechanical Circulatory Support: Activate the interventional team early for mechanical circulatory support options (IABP, Impella, or ECMO).
Acute Heart Failure / Pulmonary Edema
Decompensated Ventricular Congestion & Unload Mapping.
- Ventilatory Support: Apply high-flow oxygen and initiate early non-invasive positive pressure ventilation (BiPAP) setups.
- Preload Reduction: Administer sublingual Nitroglycerin 0.4 mg to rapidly reduce ventricular preload and afterload forces.
- Diuresis: Inject bolus intravenous loop diuretics: Furosemide 20 to 40 mg or double the home dose equivalence.
- Afterload Reduction: Start a continuous IV Nitroglycerin infusion at 10 to 20 mcg per minute, titrating upward for elevated afterload.
- Monitoring: Monitor fluid shifts, hourly urine outputs, electrolyte balances, and breathing parameters closely.
- Medication Caveat: Avoid beta-blocker drug initiations during the hyper-acute phases of volume overload decompensation.
Respiratory Emergencies
Acute Respiratory Distress Syndrome (ARDS)
Permeability Hyper-Inflammation & Protective Ventilation Mapping.
- Lung-Protective Ventilation: Establish low tidal volume ventilation at 6 mL/kg based on predicted body weight (PBW).
- Pressure Limits: Limit plateau pressures strictly to less than 30 cmH2O and driving pressures to less than 15 cmH2O.
- PEEP Optimization: Titrate positive end-expiratory pressure (PEEP) using high-PEEP versus low-FiO2 tables.
- Prone Positioning: Initiate early prone positioning sessions lasting 16 to 18 hours daily for severe PaO2/FiO2 ratios less than 150.
- Fluid Strategy: Implement a conservative fluid management strategy once hemodynamic stability is reached.
- Neuromuscular Blockade: Consider continuous neuromuscular blockade infusions if ventilator dyssynchrony persists.
Acute Respiratory Failure (Type I & II)
Hypoxemic Shunt versus Hypercapnic Ventilation Deficit Mapping.
- Diagnostics: Obtain an immediate arterial blood gas (ABG) sample to quantify systemic pH, PaO2, and PaCO2 levels.
- Type I Management (Hypoxemic): Manage hypoxemic respiratory failure via high-flow nasal cannula (HFNC) or non-rebreather systems.
- Type II Management (Hypercapnic): Address hypercapnic shifts using early non-invasive positive pressure ventilation (NIPPV).
- Monitoring: Continuously monitor patient alertness and work of breathing to detect rising respiratory fatigue.
- Oxygenation Targets: Target a peripheral oxygen saturation window of 94 to 98% for patients without chronic lung disease.
- Escalation: Prepare for rapid sequence intubation (RSI) if severe respiratory acidosis or altered sensorium occurs.
Severe Asthma Exacerbation
Hyper-reactive Bronchial Inflammation & Airflow Obstruction Rescue Mapping.
- Bronchodilators: Administer continuous nebulized Albuterol (2.5 to 5 mg) combined with Ipratropium Bromide (0.5 mg).
- Systemic Steroids: Deliver systemic corticosteroids immediately: administer Methylprednisolone 60 to 125 mg IV or oral Prednisone.
- Adjunctive Therapy: Infuse Magnesium Sulfate 2 grams IV over 20 minutes to achieve direct bronchial smooth muscle relaxation.
- Ventilatory Support: Utilize non-invasive positive pressure ventilation (BiPAP) cautiously if respiratory fatigue develops.
- Auscultation Warning: Monitor closely for a "silent chest" on auscultation, which signals critical, near-total airflow termination.
- Intubation Preparation: Prepare for emergency intubation using high-induction doses of Ketamine for its bronchodilatory properties.
COPD Exacerbation
Alveolar Air-Trapping & Tracheobronchial Infection Response Mapping.
- Oxygenation: Titrate supplemental oxygen cautiously to maintain peripheral saturation metrics strictly at 88 to 92 percent.
- Bronchodilators: Administer short-acting bronchodilators via nebulization or metered-dose inhalers with spacers.
- Corticosteroids: Deliver systemic glucocorticoids: administer Prednisone 40 mg orally daily or IV equivalent parameters.
- Ventilatory Support: Initiate early non-invasive positive pressure ventilation (BiPAP) to treat respiratory acidosis with a pH less than 7.35.
- Antimicrobials: Provide empiric antibiotic arrays (e.g., Azithromycin or Amoxicillin-Clavulanate) for up to 5 to 7 days.
- Monitoring: Monitor closely for dynamic hyperinflation or auto-PEEP tracking signs on mechanical ventilators.
Pulmonary Embolism (PE)
V/Q Mismatch & Acute Right Ventricular Afterload Shock Mapping.
- Risk Stratification: Risk-stratify the patient utilizing Wells' criteria and compute formal PERC rule exclusions.
- Diagnostics: Order a CT Pulmonary Angiography (CTPA) or V/Q scan if pre-test probability metrics match.
- Anticoagulation: Initiate therapeutic anticoagulation immediately using Unfractionated Heparin or LMWH routes.
- ECG Evaluation: Assess for right ventricular strain patterns on a 12-lead ECG (S1Q3T3, RBBB, or T-wave inversions).
- Thrombolysis: Administer immediate systemic thrombolysis (e.g., Alteplase 100 mg) if massive PE causes hypotension.
- Fluid Management: Avoid aggressive IV fluid boluses to prevent worsening right ventricular dilation and ischemia.
Pneumothorax (including Tension)
Pleural Air Accumulation & Mediastinal Displacement Relief Mapping.
- Diagnosis: Diagnose tension phenotypes clinically via tracheal deviation, absent breath sounds, and hypotension.
- Needle Decompression: Execute immediate needle decompression using a 14-gauge angiocath in the 2nd intercostal space (ICS) at the mid-clavicular line (MCL).
- Alternative Decompression Site: Alternatively, select the 4th or 5th intercostal space at the anterior axillary line.
- Tube Thoracostomy: Follow decompression immediately with the insertion of a formal large-bore tube thoracostomy.
- Stable Management: Manage stable, small primary spontaneous pneumothoraces (less than 2 cm) with high-flow oxygen lines.
- System Setup & Confirmation: Connect the chest tube to a water-seal suction system and confirm placement via chest X-ray.
Pneumonia (Severe / Sepsis-related)
Parenchymal Consolidation & Systemic Inflammatory Cascade Mapping.
- Microbiology: Draw blood cultures from two distinct peripheral sites before administering any antimicrobials.
- Empiric Therapy: Administer empiric broad-spectrum antibiotics (e.g., Ceftriaxone plus Azithromycin) within 1 hour.
- Risk Stratification: Screen for MRSA or Pseudomonas risk factors; adjust antibiotic coverage lines accordingly.
- Respiratory Monitoring: Evaluate gas exchange impairment using serial arterial blood gas or pulse oximetry metrics.
- Sepsis Management: Initiate fluid resuscitation using 30 mL/kg of crystalloids if concurrent septic shock is present.
- Severity Scoring: Compute CURB-65 or PSI scoring criteria to guide intensive care unit admission indicators.
Aspiration Pneumonitis
Corrosive Gastric Acid Chemical Burn & Secondary Hypoxemia Mapping.
- Airway Clearance: Suction the oropharynx and upper airway immediately following a witnessed aspiration event.
- Respiratory Support: Provide supplemental oxygen or non-invasive positive pressure ventilation based on hypoxemia severity.
- Antibiotic Stewardship: Avoid routine empiric antibiotic administration during the first 24 to 48 hours of chemical pneumonitis.
- Monitoring: Track serial temperatures, white blood cell counts, and chest radiographs for structural changes.
- Secondary Infection: Escalate to antimicrobial therapy only if secondary bacterial aspiration pneumonia criteria are met.
- Prevention: Optimize gastric residual volume checks and head-of-bed positioning to mitigate future risks.
Upper Airway Obstruction
Mechanical Laryngeal/Tracheal Occlusion & Critical Airway Rescue Mapping.
- Clinical Assessment: Assess for signs of complete occlusion: look for a silent chest, extreme universal distress, and aphonia.
- Foreign Body Management: Execute abdominal thrusts (Heimlich maneuver) for conscious patients with suspected foreign bodies.
- Anaphylactic Management: Administer intramuscular Epinephrine 0.3 mg immediately if laryngeal edema or anaphylaxis matches.
- Airway Instrumentation: Attempt direct laryngoscopy or video-assisted intubation utilizing a smaller endotracheal tube size.
- Preparation: Prepare an emergency cricothyroidotomy kit at the bedside prior to initiating airway manipulation.
- Definitive Surgical Airway: Establish a definitive surgical airway instantly if the conventional "cannot intubate, cannot oxygenate" (CICO) loop occurs.
Neurological Emergencies
Ischemic Stroke
Focal Cerebral Thromboembolism & Thrombolytic Window Mapping.
- Assessment: Establish the exact "Last Known Well" time and compute formal NIHSS scoring metrics.
- Imaging: Secure an emergent non-contrast head CT or MRI scan within 20 minutes to rule out hemorrhage.
- Glucose Screening: Check blood glucose levels immediately to eliminate hypoglycemia as a stroke mimic.
- Thrombolysis: Administer IV Alteplase or Tenecteplase if the patient is within the eligible 4.5-hour window.
- Blood Pressure Control: Maintain blood pressure strictly below 185/110 mmHg prior to initiating thrombolytic infusions.
- Mechanical Thrombectomy: Coordinate with endovascular neuro-interventional teams for mechanical thrombectomy windows up to 24 hours.
Intracerebral Hemorrhage (ICH)
Parenchymal Hematoma Containment & Target Hemodynamic Mapping.
- Diagnostics: Confirm the precise bleeding localization and volume via urgent non-contrast head CT imaging.
- Blood Pressure Control: Titrate short-acting IV antihypertensives (e.g., Nicardipine or Labetalol) to achieve a target systolic blood pressure (SBP) of 140 mmHg.
- Coagulation Reversal: Immediately reverse any pre-existing anticoagulation arrays (e.g., Vitamin K, Kcentra, or Andexxa Alfa).
- Hematologic Management: Check baseline coagulation profiles (PT/INR, PTT, platelets) and maintain platelet counts above 100,000/µL.
- Neurological Monitoring: Monitor closely for rising intracranial pressure, tracking rapid drops in Glasgow Coma Scale scores.
- Surgical Consultation: Consult neurosurgery early to evaluate for surgical evacuation or external ventricular drain placement.
Subarachnoid Hemorrhage (SAH)
Aneurysmal Rupture Crisis & Rebleeding Prevention Mapping.
- Diagnostics: Identify subarachnoid blood patterns on head CT or perform a lumbar puncture if clinical suspicion is high.
- Hemodynamic Control: Manage systolic blood pressure strictly below 160 mmHg using titratable IV infusions to prevent rebleeding.
- Vasospasm Prophylaxis: Initiate oral Nimodipine 60 mg every 4 hours to mitigate secondary delayed cerebral ischemia from vasospasm.
- Vascular Imaging: Secure an urgent CT angiogram or conventional digital subtraction angiography to locate the aneurysm.
- Supportive Care: Establish bed rest, administer stool softeners, and optimize pain control to avoid Valsalva-induced pressure spikes.
- Consultation: Consult neurosurgery immediately for definitive endovascular coiling or surgical clipping configurations.
Status Epilepticus
Continuous Epileptiform Escalation & Neuro-Metabolic Protection Mapping.
- Initial Stabilization: Track precise seizure duration metrics; protect the patient from physical trauma and secure the airway.
- First-Line Therapy: Administer Lorazepam 4 mg IV push or Midazolam 10 mg IM if IV access is not established.
- Escalation (5+ Minutes): Repeat a second benzodiazepine dose if motor seizure activity persists past the 5-minute mark.
- Second-Line Therapy: Infuse a second-line non-sedating antiepileptic agent, such as Levetiracetam (60 mg/kg) or Fosphenytoin (20 mg PE/kg).
- Refractory Management: Transition to continuous anesthetic infusions (e.g., Propofol or Midazolam) if seizures cross refractory thresholds.
- Neuromonitoring: Initiate continuous EEG monitoring to rule out subclinical non-convulsive status epilepticus.
Traumatic Brain Injury (TBI)
Primary Structural Neuro-Trauma & Secondary Insult Prevention Mapping.
- Airway & GCS: Calculate baseline Glasgow Coma Scale (GCS) values; secure the airway immediately if GCS is 8 or less.
- Hemodynamic Stability: Prevent secondary brain injury by maintaining systolic blood pressure strictly at or above 100 to 110 mmHg.
- Oxygenation: Avoid hypoxemia by keeping oxygen saturations at or above 94% and PaO2 greater than 60 mmHg.
- Spinal Precautions: Secure the cervical spine mechanically using a rigid collar pending radiological clearance.
- Imaging: Perform a non-contrast head CT to evaluate for epidural, subdural, or parenchymal injury patterns.
- Ventilation: Optimize arterial pCO2 parameters within a narrow physiological window (35 to 40 mmHg) to stabilize cerebral blood flow.
Increased Intracranial Pressure (ICP)
Intracranial Volumetric Crisis & Osmotic Decompression Mapping.
- Positioning: Elevate the head of the bed to 30 degrees and position the neck in a strict neutral midline alignment.
- Hyperosmolar Therapy: Administer hyperosmolar agents: infuse 20 percent Mannitol (0.25 to 1 g/kg IV) or 3 percent Hypertonic Saline boluses.
- Ventilatory Bridge: Secure intubation and implement temporary hyperventilation (pCO2 30 to 35 mmHg) as a short-term crisis bridge.
- Fluid Management: Avoid hypotonic crystalloid fluid infusions (e.g., D5W or 0.45 percent NS) to prevent worsening cerebral edema.
- Sedation: Provide adequate sedation and analgesia with Propofol or Fentanyl to limit sympathetic pressure surges.
- Neurosurgical Escalation: Prepare for emergent neurosurgical decompression if herniation signs (e.g., anisocoria or decerebrate posturing) occur.
Meningitis / Encephalitis
Meningeal Pathogen Encroachment & Empiric Antimicrobial Mapping.
- Diagnostics: Draw blood cultures instantly from two separate sites and check for focal neurological signs or papilledema.
- Adjunctive Steroids: Administer Dexamethasone 10 mg IV immediately before or alongside the first dose of antibiotics.
- Empiric Antibiotics: Infuse broad-spectrum coverage: Ceftriaxone 2g IV plus Vancomycin 15–20 mg/kg IV.
- Listeria Coverage: Add Ampicillin 2g IV if the patient is aged over 50 or immunocompromised to target Listeria monocytogenes.
- Antiviral Coverage: Include Acyclovir 10 mg/kg IV if clinical features point toward Herpetic (HSV) Encephalitis.
- Lumbar Puncture: Perform a lumbar puncture immediately after head CT confirmation rules out space-occupying lesions.
Delirium (ICU/ED)
Acute Cognitive Fluctuation & Neuro-Environmental Harmonization Mapping.
- Screening: Screen for delirium patterns systematically using the CAM-ICU or ICDSC validated scales.
- Trigger Identification: Identify and address underlying physiological triggers: review medications, resolve hypoxia, or treat infections.
- Non-Pharmacological Protocol: Implement non-pharmacological protocols: re-orient frequently, encourage early mobility, and minimize noise.
- Circadian Management: Restore physiological circadian rhythm tracks by optimizing daylight exposure and night sleep conditions.
- Medication Review: Discontinue or minimize deliriogenic infusions, specifically targeting Benzodiazepines and Anticholinergics.
- Pharmacological Reserve: Reserve low-dose Dexmedetomidine or atypical antipsychotics strictly for hyperactive agitation risks.
Coma / Altered Mental Status
Undifferentiated Sensorium Depression & Systematic Etiology Diagnostics Mapping.
- Immediate Glucose: Check a point-of-care fingerstick blood glucose reading instantly to exclude hypoglycemia.
- Differential Diagnosis: Run the comprehensive "AEIOU TIPS" diagnostic framework to systematically scan for metabolic or structural origins.
- Neurological Exam: Assess pupil reactivity, extraocular movements, corneal reflexes, and symmetric motor patterns.
- Reversal Agents: Administer Naloxone 0.4 to 2 mg IV if clinical features indicate opioid-induced hypoventilation states.
- Airway Management: Secure a definitive airway with an endotracheal tube if the Glasgow Coma Scale score is 8 or less.
- Work-up: Order urgent metabolic panels, blood gas evaluations, toxin screens, and emergency brain imaging.
Shock & Critical Illness Syndromes
Septic Shock
Dysregulated Systemic Perfusion & Vasoactive Resource Mapping.
- Fluid Resuscitation: Initiate an explicit crystalloid fluid resuscitation loop of 30 mL/kg within the first 3 hours.
- Microbiology: Draw two separate sets of blood cultures immediately before infusing broad-spectrum antimicrobials.
- First-Line Vasopressor: Establish a continuous central infusion of Norepinephrine as the absolute first-line vasopressor therapy.
- MAP Targets: Titrate vasoactive doses aggressively to maintain a mean arterial pressure (MAP) of 65 mmHg or greater.
- Adjunctive Therapy: Add Vasopressin at 0.03 units/min if Norepinephrine escalations fail to stabilize systemic target lines.
- Perfusion Monitoring: Monitor serial serum lactate levels every 2 to 4 hours to verify systemic tissue perfusion recovery.
Sepsis
Host-Response Inflammation & Acute Organ Dysfunction Protection Mapping.
- Risk Stratification: Screen susceptible patients immediately using Sequential Organ Failure Assessment (SOFA) scoring metrics.
- Early Recognition: Recognize subtle shifts: track altered sensorium, tachypnea (≥ 22/min), or systolic blood pressure (≤ 100 mmHg).
- Source Control: Identify the infectious driver rapidly via targeted imaging, chest X-rays, and body fluid cultures.
- Antimicrobial Therapy: Administer empiric, wide-spectrum intravenous antimicrobials within 1 hour of sepsis recognition.
- Laboratory Monitoring: Order serial complete blood counts, coagulation profiles, liver panels, and kidney biomarkers.
- Fluid Stewardship: Establish clear maintenance fluid volumes and reassess volume status parameters frequently.
Hypovolemic Shock
Intravascular Volume Deficit & Hemorrhagic Source Control Mapping.
- Access: Establish two large-bore (14–16 gauge) peripheral IV access routes or an intraosseous line immediately.
- MTP Activation: Activate a Massive Transfusion Protocol (MTP) early if active, severe hemorrhagic blood loss is identified.
- Balanced Resuscitation: Transfuse balanced blood products matching a strict 1:1:1 ratio (packed RBCs, plasma, and platelets).
- Source Control: Achieve immediate mechanical source control using tourniquets, direct pressure, or pelvic binders.
- Fluid Boluses: Administer rapid balanced crystalloid boluses cautiously for non-hemorrhagic fluid depletion states.
- Vasoactive Timing: Delay vasopressor configurations until intravascular volume parameters are effectively replenished.
Obstructive Shock
Mechanical Outflow Impairment & Immediate Thoracic Decompression Mapping.
- Diagnostics: Perform a rapid bedside point-of-care ultrasound (POCUS) to identify tamponade or RV strain indicators.
- Tension Pneumothorax: Execute urgent needle decompression or finger thoracostomy if a tension pneumothorax profile matches.
- Cardiac Tamponade: Perform emergency bedside pericardiocentesis under direct ultrasound guidance for cardiac tamponade.
- Pulmonary Embolism: Initiate systemic thrombolytic therapies or catheter embolectomy paths for proven massive PE.
- Fluid Optimization: Deliver careful, small isotonic fluid boluses to maintain right ventricular preload during stabilization.
- Ventilatory Caution: Avoid positive-pressure ventilation shifts if possible, as they can cause immediate hemodynamic collapse.
Anaphylactic Shock
IgE-Mediated Vasodilatory Collapse & Mast-Cell Degranulation Rescue Mapping.
- First-Line Treatment: Administer Epinephrine (1:1000) 0.3–0.5 mg intramuscularly into the anterolateral thigh instantly.
- Dose Repeat: Repeat the intramuscular Epinephrine injection every 5–15 minutes if symptoms remain refractory.
- Airway Management: Secure high-flow supplemental oxygen and prepare for a potentially challenging, early endotracheal intubation.
- Fluid Resuscitation: Infuse aggressive, rapid crystalloid fluid boluses (1–2 liters) to treat profound distributive vasodilation.
- Adjunctive Therapy: Administer secondary agents: IV Methylprednisolone, Diphenhydramine, and Famotidine.
- Vasopressor Escalation: Establish a continuous, titratable IV Epinephrine infusion if systemic hypotension resists IM injections.
Multiorgan Dysfunction Syndrome (MODS)
Progressive Sequential Homeostatic Deficit & Organ Support Mapping.
- Monitoring: Identify secondary organ system failures via serial tracking of lab metrics and clinical parameters.
- Ventilatory Protection: Optimize mechanical ventilator settings to prevent secondary lung injury (VILI) and auto-PEEP loops.
- Renal Support: Support renal perfusion deficiencies early using continuous renal replacement therapy (CRRT) as indicated.
- Metabolic Management: Implement strict, protective glycemic control targets alongside balanced enteral nutrition protocols.
- Hematologic Correction: Correct ongoing coagulopathy profiles using targeted cryoprecipitate, plasma, or platelet infusions.
- Drug Stewardship: Review all active pharmaceutical profiles daily to prevent cumulative drug toxicities or interactions.
Metabolic / Endocrine Emergencies
Diabetic Ketoacidosis (DKA)
Hyperglycemic Ketotic Acidosis & Intravenous Insulin Mapping.
- Fluid Resuscitation: Initiate rapid fluid volume restoration using 1 to 1.5 L of 0.9 percent Normal Saline in the first hour.
- Potassium Safety: Check serum potassium levels immediately prior to introducing any insulin medications.
- Potassium Correction: If potassium is less than 3.3 mEq/L, hold insulin and administer 20 to 30 mEq/h of potassium until levels rise.
- Insulin Infusion: Start a continuous regular insulin infusion at 0.1 units/kg/h once potassium tracks above 3.3 mEq/L.
- Glucose Management: Transition maintenance fluids to D5 percent with 0.45 percent Saline when blood glucose falls below 250 mg/dL.
- Monitoring: Monitor the systemic anion gap and venous pH parameters closely until absolute resolution is met.
Hyperosmolar Hyperglycemic State (HHS)
Profound Hyperosmolality & Cellular Dehydration Correction Mapping.
- Volume Resuscitation: Prioritize massive fluid volume resuscitation, anticipating typical deficits of 8 to 10 liters.
- Fluid Selection: Infuse 0.9 percent or 0.45 percent Normal Saline depending on calculated corrected serum sodium metrics.
- Insulin Therapy: Administer a conservative continuous regular insulin infusion at 0.05 to 0.1 units/kg/h settings.
- Rate of Correction: Reduce blood glucose parameters gradually by 50 to 75 mg/dL per hour to prevent fluid shift injuries.
- Glucose Maintenance: Add 5 percent Dextrose to the fluid regimen once blood glucose levels hit a 300 mg/dL threshold.
- Clinical Monitoring: Monitor serial serum osmolality measurements and neurological status indicators frequently.
Hypoglycemia
Neuroglycopenic Crisis Emergency Counter-Regulation Mapping.
- Verification: Verify fingerstick blood glucose levels instantly if neuroglycopenic signs match.
- Oral Correction: Provide 15–20g of fast-acting oral carbohydrates if the patient is fully awake and able to swallow.
- IV Correction: Administer 50 mL of 50 percent Dextrose (D50W) or 100 mL of D10W intravenously if the patient is unconscious.
- IM/SQ Correction: Inject 1 mg of Glucagon intramuscularly or subcutaneously if intravenous access cannot be established.
- Re-assessment: Recheck point-of-care blood glucose measurements every 15 minutes until parameters exceed 70 mg/dL.
- Refractory Management: Initiate a continuous 10 percent Dextrose infusion for refractory cases, such as sulfonylurea overdose.
Hyperkalemia
Myocardial Membrane Stabilization & Potassium Elimination Mapping.
- Cardiac Screening: Obtain an immediate 12-lead ECG to screen for peaked T waves, PR prolongation, or sine-wave patterns.
- Membrane Stabilization: Administer 10 mL of 10 percent Calcium Gluconate IV over 5 to 10 minutes to stabilize cardiac membranes.
- Intracellular Shift (Insulin): Drive potassium intracellularly by infusing 10 units of regular insulin alongside 50 mL of D50W.
- Intracellular Shift (Beta-Agonist): Include continuous nebulized Albuterol treatments (10 to 20 mg) to augment intracellular shifting.
- Acidosis Correction: Administer Sodium Bicarbonate IV if severe concurrent metabolic acidosis parameters are noted.
- Potassium Elimination: Eliminate bodily potassium using loop diuretics, oral binding resins (e.g., Sodium Polystyrene Sulfonate or Patiromer), or emergent hemodialysis.
Hyponatremia (Severe Symptomatic)
Acute Hypo-Osmolar Cerebral Edema Decompression Mapping.
- Recognition: Identify severe neuro-deficit presentation flags: track status epilepticus, coma, or signs of cerebral herniation.
- Initial Correction: Administer a 100 mL bolus of 3 percent Hypertonic Saline intravenously over a prompt 10-minute window.
- Escalation: Repeat the 3 percent Hypertonic Saline bolus up to twice if active seizure activity continues.
- Correction Limits: Limit absolute serum sodium correction increments strictly to less than 8 mEq/L within any 24-hour cycle.
- Frequent Monitoring: Monitor serum sodium levels every 2 hours to avoid hyper-correction past recommended targets.
- Risk Mitigation: Understand that overly rapid correction can trigger irreversible Osmotic Demyelination Syndrome (formerly Central Pontine Myelinolysis).
Hypernatremia
Free Water Intracellular Deficit & Volume Equalizing Mapping.
- Volume Assessment: Determine baseline volume profiles to differentiate hypovolemic, euvolemic, and hypervolemic states.
- Deficit Calculation: Compute the Free Water Deficit to guide volume replenishment parameters.
- Replacement Therapy: Infuse hypotonic fluid tracks (e.g., D5W or 0.45% Saline) or provide oral water routes as indicated.
- Correction Velocity: Maintain safe correction velocities, limiting sodium decreases strictly to less than 10 mEq/L within a 24-hour window.
- Cerebral Protection: Avoid rapid corrections to prevent precipitating localized cerebral edema or structural brain injury.
- Serial Monitoring: Track serum sodium profiles every 4–6 hours to continuously calibrate free-water input vectors.
Hypocalcemia
Neuromuscular Hyper-Excitability & Ionized Fraction Rescue Mapping.
- Physical Exam: Assess for positive Chvostek's or Trousseau's signs and review baseline ECG for QTc prolongation.
- Diagnostic Assessment: Check ionized calcium levels directly to bypass alterations caused by fluctuating serum albumin.
- Acute Therapy: Administer 10–20 mL of 10 percent Calcium Gluconate IV over 10 minutes for severe, symptomatic states.
- Administration Safety: Ensure slow IV administration rates to mitigate the risk of severe bradycardia or cardiac dysrhythmias.
- Co-factor Management: Check and correct concurrent hypomagnesemia, as low magnesium levels can cause refractory hypocalcemia.
- Maintenance: Transition the patient to long-term oral calcium and Vitamin D supplementation protocols once stable.
Thyroid Storm
Decompensated Hypermetabolic Hyperthyroid De-escalation Mapping.
- Severity Assessment: Compute a Burch-Wartofsky score to gauge the clinical severity indices of thyrotoxicosis.
- Sympathetic Blockade: Administer IV Propranolol or Esmolol to counter severe tachycardia and inhibit peripheral T4-to-T3 conversion.
- Antithyroid Loading: Provide Propylthiouracil (PTU) 600–1000 mg orally or rectally as the preferred first-line antithyroid agent.
- Hormonal Blockade: Wait at least 1 hour after PTU administration before infusing iodine (e.g., Lugol’s solution) to block the release of preformed hormone.
- Adrenal Support: Administer Hydrocortisone 100 mg IV every 8 hours to treat potential relative adrenal insufficiency.
- Supportive Care: Apply external cooling blankets and avoid salicylates (e.g., Aspirin), as they can displace thyroid hormones from binding proteins and increase free levels.
Myxedema Coma
Profound Hypothyroid Neuro-Metabolic Resuscitation Mapping.
- Airway Management: Secure early endotracheal intubation if progressive hypercapnic respiratory failure is identified.
- Thermoregulation: Initiate active, cautious gentle external rewarming paths; avoid rapid rewarming to prevent vasodilation and hypotension.
- Adrenal Protection: Administer Hydrocortisone 100 mg IV immediately to protect against concurrent adrenal insufficiency before thyroid replacement.
- Thyroid Replacement: Deliver an IV loading dose of Levothyroxine (T4) 200–400 mcg, followed by daily maintenance.
- T3 Therapy: Consider adding low-dose Liothyronine (T3) paths based on critical endocrinology consult guidance.
- Fluid Management: Limit fluid volume inputs to avoid worsening severe, dilutional hyponatremia.
Adrenal Crisis
Acute Corticoid Insufficiency & Refractory Vasomotor Rescue Mapping.
- Recognition: Identify refractory vascular shock that remains unresponsive to aggressive crystalloid fluid resuscitation.
- Immediate Treatment: Administer Hydrocortisone 100 mg IV push immediately; do not delay treatment for lab diagnostic results.
- Diagnostic Sampling: Draw baseline random serum cortisol and ACTH levels immediately prior to the hydrocortisone push.
- Fluid Resuscitation: Infuse D5 percent in 0.9 percent Normal Saline to reverse concurrent hypoglycemia and sodium depletion.
- Electrolyte Management: Monitor and correct electrolyte shifts, specifically focusing on severe hyperkalemia or hyponatremia trends.
- Stabilization: Transition to standard maintenance corticosteroid dosing schedules once hemodynamic parameters are stable.
Renal & Electrolyte Emergencies
Acute Kidney Injury (AKI)
Abrupt GFR Deterioration & Nephrotoxic Elimination Mapping.
- Staging: Stage severity immediately using KDIGO guidelines based on serum creatinine changes and urine output.
- Toxin Mitigation: Discontinue all nephrotoxic agents (e.g., NSAIDs, aminoglycosides, iodinated contrast) immediately.
- Etiology: Differentiate the underlying etiology systematically by categorizing as prerenal, intrinsic, or postrenal.
- Imaging: Order a point-of-care renal ultrasound within 24 hours to exclude structural postrenal obstruction.
- Hemodynamic Optimization: Optimize mean arterial pressure and perfusion carefully with isotonic crystalloids for prerenal dehydration.
- Dialysis Evaluation: Assess continuously for the definitive "AEIOU" indications (Acidosis, Electrolytes, Ingestion, Overload, Uremia) that mandate emergent renal replacement therapy.
Uremic Encephalopathy
Nitrogenous Toxin Accumulation & Neuro-Metabolic Resuscitation Mapping.
- Assessment: Check serum blood urea nitrogen (BUN) and creatinine levels instantly if altered sensorium presents.
- Neuromuscular Screening: Assess for objective signs of neuromuscular irritability, specifically tracking asterixis, clonus, or hyperreflexia.
- Airway & Safety: Secure the patient's airway and establish seizure precautions if generalized motor seizures occur.
- Medication Stewardship: Avoid neuroleptic or sedating medications that can mask clinical progression or worsen encephalopathy.
- Consultation: Consult nephrology immediately to initiate emergency vascular access and renal replacement therapy (RRT).
- Monitoring: Monitor for concurrent severe metabolic acidosis and hyperkalemia patterns during dialysis preparation.
Severe Fluid Overload / Pulmonary Edema (Renal)
Decompensated Hypervolemia & Ultrafiltration Optimization Mapping.
- Ventilatory Support: Apply continuous non-invasive positive pressure ventilation (BiPAP) to recruit fluid-filled alveoli and reduce preload.
- Diuresis: Administer high-dose intravenous loop diuretics (e.g., Furosemide 80–120 mg IV or doubling the total daily home dose).
- Vasodilation: Infuse IV Nitroglycerin concurrently to decrease venous return (preload) and reduce cardiac afterload.
- Fluid Stewardship: Maintain strict fluid restriction and insert a Foley catheter to monitor precise hourly urine output.
- Sequential Blockade: Add thiazide-like diuretics (e.g., Metolazone) if loop diuretic resistance is clinically identified.
- RRT Coordination: Coordinate emergent ultrafiltration or hemodialysis immediately if the patient remains anuric or refractory to pharmacological management.
Severe Acid-Base Disorders
Critical H+ Ion Dysregulation & Physiological Buffer Balancing Mapping.
- Diagnostics: Obtain an arterial blood gas (ABG) alongside a comprehensive metabolic panel to measure systemic pH.
- Anion Gap Calculation: Calculate the anion gap using the formula: [Na+] - ([Cl-] + [HCO3-]) to characterize metabolic acidosis pathways.
- Delta-Delta Ratio: Compute the delta-delta ratio if an elevated anion gap is found to identify concomitant metabolic disorders.
- Source Management: Treat the primary driving pathology (e.g., source control for sepsis, insulin for DKA, antidotes for toxic ingestions).
- Bicarbonate Therapy: Consider cautious Sodium Bicarbonate IV infusions only if pH < 7.10 and associated with severe hemodynamic instability.
- Extracorporeal Support: Arrange emergency hemodialysis for profound, refractory metabolic acidosis unresponsive to medical stabilization.
Infectious Diseases (Critical Care)
Severe Sepsis
Infection-Induced Hypoperfusion & Organ Failure Protection Mapping.
- Organ Dysfunction: Identify organ failure metrics: monitor for acute oliguria, rising creatinine, or altered mental status.
- Lactate Clearance: Check point-of-care serum lactate measurements immediately to quantify tissue hypoperfusion.
- Fluid Resuscitation: Deliver an early, structured balanced crystalloid fluid resuscitation bundle (30 mL/kg).
- Microbial Sampling: Draw two separate sets of blood cultures and obtain targeted localized source samples within 45 minutes.
- Antimicrobial Therapy: Administer empiric, broad-spectrum IV antimicrobials immediately without waiting for culture results.
- Dynamic Assessment: Reassess fluid responsiveness continuously using dynamic measures like passive leg raises or stroke volume variation.
Septic Shock (ID Context)
Refractory Circulatory Failure & Operative Source Control Mapping.
- Recognition: Identify systemic circulatory failure that persists despite completing the initial 30 mL/kg fluid resuscitation bundle.
- Vasopressor Support: Initiate a continuous central infusion of Norepinephrine immediately to maintain a target Mean Arterial Pressure (MAP) ≥ 65 mmHg.
- Device Management: Mobilize the team for immediate source control: locate and remove any suspected infected lines, catheters, or devices.
- Surgical Intervention: Arrange for urgent surgical incision, drainage, or debridement of any deep tissue infection focus or abscess.
- Refractory Support: Add adjunctive IV Hydrocortisone (200 mg/day, divided or continuous) if vasoactive requirements continue to escalate.
- Hemodynamic Monitoring: Monitor Central Venous Oxygen Saturation (ScvO2) and track lactate clearance timelines at least every 2 hours.
COVID-19 Severe Pneumonia / ARDS
SARS-CoV-2 Hyper-Inflammatory Pneumonitis & Oxygenation Mapping.
- Corticosteroids: Administer Dexamethasone 6 mg IV or orally daily to curb progressive, immune-mediated alveolar damage.
- Respiratory Support: Apply high-flow nasal cannula (HFNC) or non-invasive positive pressure ventilation (BiPAP) to treat refractory hypoxemia.
- Prone Positioning: Implement an early awake prone positioning protocol to optimize ventilation-perfusion (V/Q) matching zones.
- Anticoagulation: Screen for thromboembolic developments; administer therapeutic or enhanced prophylactic doses of low-molecular-weight heparin (LMWH).
- Immunomodulation: Incorporate interleukin-6 receptor antagonists (e.g., Tocilizumab) within 24 hours of ICU admission for patients meeting specific inflammatory thresholds.
- Mechanical Ventilation: Transition to protective, low-tidal-volume mechanical ventilation (6 mL/kg PBW) if the patient exhibits signs of fatigue or worsening respiratory failure.
Bacterial Meningitis
Subarachnoid Space Suppuration & Meningeal Decompression Mapping.
- Adjunctive Therapy: Administer Dexamethasone 10 mg IV immediately before or alongside the first dose of empiric antibiotics to reduce neuro-inflammation.
- Empiric Antimicrobials: Infuse Ceftriaxone 2 g IV every 12 hours plus Vancomycin 15–20 mg/kg IV (dosed to troughs).
- Listeria Coverage: Add Ampicillin 2 g IV if the patient is over age 50, immunocompromised, or presents with other specific risk variables for Listeria monocytogenes.
- Pre-LP Imaging: Obtain a non-contrast head CT scan rapidly to rule out space-occupying lesions or signs of mass effect before performing a lumbar puncture (LP).
- Diagnostic Sampling: Perform LP immediately after imaging to measure opening pressure and analyze cerebrospinal fluid (CSF).
- Infection Control: Implement strict droplet isolation precautions for at least the first 24 hours of targeted antimicrobial therapy.
Necrotizing Soft Tissue Infection (NSTI)
Fascial Plane Destruction & Emergent Operative Debridement Mapping.
- Early Recognition: Maintain high suspicion for NSTI if soft tissue swelling presents with severe, disproportionate pain (pain out of proportion to exam findings).
- Late Indicators: Identify late-stage pathognomonic flags: track localized crepitus, hemorrhagic bullae, or frank skin necrosis.
- Surgical Activation: Activate the surgical service immediately for emergency operative incision, tracking, and aggressive, wide debridement.
- Broad-Spectrum Therapy: Start empiric antimicrobial arrays (e.g., Vancomycin plus Piperacillin/Tazobactam or a Carbapenem).
- Toxin Suppression: Add Clindamycin 900 mg IV every 8 hours to inhibit bacterial protein synthesis and suppress exotoxin production.
- Re-exploration: Prepare for repeated, scheduled surgical re-exploration procedures within a 24-hour interval to ensure source control.
Septic Arthritis (Critical Cases)
Synovial Space Suppurative Invasion & Articular Preservation Mapping.
- Clinical Recognition: Identify acute-onset monoarticular joint swelling paired with profound restriction in passive and active range of motion.
- Arthrocentesis: Perform urgent joint aspiration under sterile conditions to obtain synovial fluid for immediate diagnostic evaluation.
- Laboratory Analysis: Submit joint fluid for urgent Gram stain, synovial leukocyte count with differential, and aerobic/anaerobic cultures.
- Antimicrobial Therapy: Initiate targeted IV anti-staphylococcal therapies (e.g., Vancomycin) promptly following joint aspiration.
- Surgical Consultation: Coordinate with orthopedic surgery for immediate arthroscopic irrigation or formal open joint arthrotomy/drainage.
- Post-Surgical Care: Immobilize the joint briefly in a functional position, followed by early passive range-of-motion recovery protocols to prevent contractures.
Tuberculosis (Miliary / Severe)
Hematogenous Dissemination & Airborne Containment Rescue Mapping.
- Infection Control: Place the patient in a negative-pressure airborne infection isolation room (AIIR) immediately upon clinical suspicion.
- Imaging: Order chest radiographs or high-resolution CT scans to identify classic diffuse, micronodular (miliary) infiltration patterns.
- Microbiological Sampling: Obtain serial sputum samples for acid-fast bacilli (AFB) smears and rapid nucleic acid amplification testing (NAAT).
- Standard Therapy: Initiate standard four-drug anti-tuberculosis therapy (Rifampin, Isoniazid, Pyrazinamide, and Ethambutol) arrays immediately.
- CNS Screening: Perform a comprehensive neurological evaluation and consider lumbar puncture to screen for concurrent tuberculous meningitis.
- Adjunctive Therapy: Add systemic corticosteroid therapy if central nervous system involvement or severe pericardial effusion/inflammation is confirmed.
Gastrointestinal / Hepatic Emergencies
Upper GI Bleeding
Proximal Luminal Hemorrhage & Endoscopic Localization Mapping.
- Hemodynamic Stabilization: Assess hemodynamic parameters immediately; establish two large-bore (14–16 gauge) peripheral IV lines.
- Restrictive Transfusion: Transfuse packed red blood cells restrictively to maintain a target hemoglobin level ≥ 7–8 g/dL.
- Acid Suppression: Administer an IV bolus of 80 mg Esomeprazole or Pantoprazole, followed by a continuous 8 mg/h infusion.
- Coagulation Management: Reverse pre-existing coagulopathy or antithrombotic therapies cautiously based on the severity of active bleeding.
- Endoscopic Planning: Coordinate with gastroenterology to secure an emergency diagnostic and therapeutic endoscopy, ideally within 24 hours.
- Prokinetic Therapy: Consider a continuous Erythromycin IV infusion (250 mg) 30 minutes prior to endoscopy to optimize visualization by promoting gastric emptying.
Lower GI Bleeding
Distal Colonic Extravasation & Hemodynamic Source Mapping.
- Source Exclusion: Evaluate for hemodynamic instability; perform a diagnostic nasogastric lavage (or upper endoscopy) to rule out a brisk upper GI source.
- Resuscitation: Initiate aggressive crystalloid volume resuscitation or blood transfusion arrays if hematochezia causes clinical instability or shock.
- Risk Stratification: Compute a formal Oakland score to risk-stratify the patient and determine the safe disposition (outpatient vs. inpatient).
- Colonoscopic Management: Schedule a rapid colonoscopy following a structured, high-volume polyethylene glycol (PEG) colonic purge.
- Diagnostic Imaging: Arrange for urgent CT Angiography (CTA) if severe, unremitting bleeding prevents safe or effective bowel preparation.
- Interventional Support: Coordinate with interventional radiology (IR) for potential transcatheter embolization if a localized contrast blush is confirmed on CTA.
Acute Pancreatitis (Severe)
Capillary Leak Inflammatory Cascade & Goal-Directed Volume Mapping.
- Fluid Resuscitation: Implement aggressive, goal-directed fluid resuscitation using Lactated Ringer's solution at 250–500 mL/h.
- Volume Monitoring: Track responses closely by measuring hourly urine output (target ≥ 0.5 mL/kg/h) and observing trends in blood urea nitrogen (BUN).
- Safety Calibration: Re-evaluate fluid input requirements every 4–6 hours to mitigate the risk of fluid overload and abdominal compartment syndrome.
- Analgesia: Provide optimized, multi-modal analgesia using IV opioids or patient-controlled analgesia (PCA) protocols.
- Nutritional Support: Prioritize early enteral nutrition via oral or post-pyloric feeding routes over total parenteral nutrition (TPN).
- Infection Control: Avoid routine prophylactic antibiotic use; reserve therapy for patients with documented evidence of infected pancreatic necrosis.
Acute Liver Failure
Hyper-Acute Hepatic Necrosis & Neuro-Metabolic Safeguard Mapping.
- Diagnostic Criteria: Confirm the absence of underlying cirrhosis, coupled with acute coagulopathy (INR > 1.5) and any degree of hepatic encephalopathy.
- Metabolic Monitoring: Check point-of-care fingerstick blood glucose measurements every 2 hours; treat severe hypoglycemia aggressively with dextrose.
- Pharmacotherapy: Implement a broad N-Acetylcysteine (NAC) infusion protocol regardless of the suspected underlying etiology.
- Neurological Protection: Elevate the head of the bed to 30 degrees and minimize stimulation to proactively mitigate rising intracranial pressure (ICP) from cerebral edema.
- Neuro-Monitoring: Monitor arterial ammonia levels and severely restrict or avoid sedating agents to preserve the ability to track serial neurological metrics.
- Transplant Referral: Contact a regional liver transplantation center immediately to initiate emergency listing eligibility evaluation.
Decompensated Liver Cirrhosis
Portal Hypertension Decompensation & Peritoneal Infection Screening Mapping.
- Paracentesis: Perform a diagnostic paracentesis within 12 hours of admission for any patient presenting with new-onset or worsening ascites.
- SBP Screening: Analyze peritoneal fluid samples for absolute neutrophil count (ANC) to rule out Spontaneous Bacterial Peritonitis (SBP).
- Infection Management: Initiate empiric IV Ceftriaxone 2 g daily if the ascitic fluid ANC is ≥ 250 cells/mm³.
- Renal Protection: Concurrently infuse IV Albumin (1.5 g/kg on day 1; 1 g/kg on day 3) to prevent hepatorenal syndrome (HRS).
- Hepatic Encephalopathy: Administer Lactulose titration (orally or via enema) to target 2–3 soft bowel movements daily.
- Monitoring: Monitor serial serum electrolytes and creatinine to track the early development of hepatorenal or portal-systemic shifts.
Variceal Bleeding
Splanchnic Hemodynamic Crisis & Endoscopic Banding Rescue Mapping.
- Vasoactive Therapy: Start a continuous IV Octreotide infusion at 50 mcg/h following an initial 50 mcg bolus immediately.
- Prophylactic Antibiotics: Administer prophylactic IV Ceftriaxone 1 g every 24 hours to reduce infectious complications and mortality.
- Restrictive Transfusion: Maintain a restrictive transfusion strategy, targeting a hemoglobin threshold of approximately 7 g/dL.
- Volume Management: Avoid over-resuscitation to prevent rebound surges in portal venous pressures that could trigger re-bleeding.
- Endoscopic Intervention: Arrange for emergency upper endoscopy for definitive variceal band ligation (EVL) within 12 hours of initial stabilization.
- Rescue Bridge: Have a Sengstaken-Blakemore or Minnesota tube prepared at the bedside as a temporary mechanical balloon tamponade bridge for refractory hemorrhage.
Bowel Obstruction
Luminal Occlusion Decompression & Strangulation Surveillance Mapping.
- Decompression: Place a large-bore nasogastric (NG) tube to low intermittent suction for immediate upper GI decompression.
- Fluid Stewardship: Maintain strict NPO (nothing by mouth) status and initiate balanced isotonic crystalloid maintenance infusions to correct volume deficits.
- Diagnostic Imaging: Obtain a contrast-enhanced CT scan of the abdomen and pelvis to define the transition zone, etiology, and presence of high-grade vs. low-grade obstruction.
- Strangulation Surveillance: Assess sequentially for clinical signs of bowel ischemia or strangulation: worsening tachycardia, fever, or localized peritoneal signs (rebound/guarding).
- Laboratory Monitoring: Monitor for laboratory indicators of structural necrosis, specifically tracking escalating leukocytosis and rising serum lactate.
- Surgical Consultation: Consult general surgery early to determine the optimal timing for operative intervention versus conservative (non-operative) management.
Perforated Viscus / Peritonitis
Pneumoperitoneum Contamination & Emergent Operative Laparotomy Mapping.
- Diagnostics: Obtain an erect chest radiograph or cross-sectional abdominal CT to evaluate for free intraperitoneal air (pneumoperitoneum).
- Clinical Recognition: Identify signs of a rigid, board-like abdomen with rebound tenderness, indicative of chemical or bacterial peritonitis.
- Surgical Intervention: Secure immediate general surgery consultation for emergency exploratory laparotomy or laparoscopic repair.
- Antimicrobial Therapy: Administer wide-spectrum empiric IV antimicrobials (e.g., Piperacillin/Tazobactam) within 1 hour of recognition.
- Resuscitation: Implement aggressive crystalloid fluid resuscitation protocols to counter sepsis-driven distributive volume shifts.
- Hemodynamic Monitoring: Insert an indwelling urinary catheter for output monitoring and establish continuous intra-arterial blood pressure tracking.
Trauma & Surgical Emergencies
Polytrauma
Systemic Multi-System Impact & Priority-Based ATLS Mapping.
- C-Spine Stabilization: Establish immediate manual in-line stabilization of the cervical spine during primary airway evaluation.
- Airway & Breathing: Clear the oropharynx, establish a definitive airway, and optimize breathing via high-flow oxygen.
- Vascular Access: Secure two large-bore peripheral IV lines and draw blood samples for type and crossmatching instantly.
- Primary Survey: Execute an immediate primary survey focusing sequentially on Airway (with C-spine), Breathing, Circulation, Disability (neurological status), and Exposure.
- Point-of-Care Imaging: Perform an emergent bedside Focused Assessment with Sonography for Trauma (FAST) exam.
- Surgical Coordination: Coordinate with trauma surgery services for urgent transfer or operative intervention if stability thresholds fail.
Hemorrhagic Shock (Trauma)
Exsanguinating Intravascular Depletion & Massive Transfusion Ratio Mapping.
- MTP Activation: Activate the institutional Massive Transfusion Protocol (MTP) immediately upon identifying signs of profound hemorrhagic shock.
- Balanced Resuscitation: Transfuse blood products following a balanced 1:1:1 ratio of packed RBCs, fresh frozen plasma, and platelets.
- Fluid Stewardship: Limit crystalloid boluses to avoid dilutional coagulopathy and the mechanical disruption of nascent clots.
- Permissive Hypotension: Maintain permissive hypotension, targeting a systolic blood pressure (SBP) of 80–90 mmHg in patients without traumatic brain injury.
- Antifibrinolytic Therapy: Administer Tranexamic Acid (TXA) 1 g IV bolus over 10 minutes within the first 3 hours of injury.
- The Lethal Triad: Aggressively monitor and correct the "Lethal Triad": hypothermia, metabolic acidosis, and coagulopathy.
Traumatic Hemothorax
Pleural Blood Accumulation & Surgical Thoracotomy Threshold Mapping.
- Diagnosis: Confirm the presence of significant blood pooling in the pleural space via chest X-ray or point-of-care ultrasound (POCUS).
- Decompression: Perform a prompt large-bore tube thoracostomy (28–32 French) to evacuate blood and track ongoing losses.
- Massive Hemothorax Criteria: Record initial output instantly; if the initial drain exceeds 1500 mL, prepare for an emergent thoracotomy.
- Ongoing Hemorrhage Criteria: Monitor hourly output; continuous drainage > 200 mL/h for 3 consecutive hours requires urgent operative intervention.
- Auto-transfusion: Consider auto-transfusion capability (if equipment is available) to safely return evacuated blood to the central circulation.
- Complication Prevention: Follow clinical and radiographic progression closely to prevent secondary structural lung entrapment (fibrothorax) or empyema.
Traumatic Pneumothorax
Parenchymal Laceration Air Leak & Mechanical Ventilation Safeguard Mapping.
- Clinical Recognition: Identify decreased breath sounds, hyperresonance on percussion, and localized chest wall structural trauma signs.
- Conservative Management: Manage small, stable, simple traumatic pneumothoraces (< 20%) conservatively with serial imaging and high-flow supplemental oxygen.
- Tube Thoracostomy: Insert a tube thoracostomy if the pneumothorax is large, expanding, or causing significant patient symptoms.
- Ventilatory Precautions: Proactively upgrade any simple pneumothorax to a chest tube if the patient requires positive-pressure mechanical ventilation to prevent tension conversion.
- Air-Leak Monitoring: Monitor air-leak columns on water-seal drainage systems to verify structural parenchymal healing.
- Serial Imaging: Perform a repeat chest radiograph 4–6 hours following any drainage or ventilation intervention to confirm expansion metrics.
Abdominal Trauma (Solid Organ)
Intra-Peritoneal Solid Organ Injury & Non-Operative Surveillance Mapping.
- Rapid Screening: Execute an immediate bedside Focused Assessment with Sonography for Trauma (FAST) exam to screen for free fluid or hemorrhage in dependent abdominal zones.
- Unstable Management: Proceed directly to an emergent exploratory laparotomy if the patient remains hemodynamically unstable with a positive FAST.
- Diagnostic Imaging: Order a contrast-enhanced CT scan of the abdomen and pelvis if the patient is stable to formally grade organ lacerations (e.g., AAST grades).
- Non-Operative Management (NOM): Manage stable liver, spleen, or kidney injuries conservatively via strict bed rest and serial hemoglobin/hematocrit checks.
- Serial Evaluation: Perform frequent, serial abdominal examinations over 24–48 hours to detect clinical signs of peritonitis early.
- Interventional Support: Coordinate with interventional radiology (IR) for angiographic embolization if a localized arterial blush (contrast extravasation) is identified on CT.
Pelvic Fracture with Bleeding
High-Energy Pelvic Ring Disruption & Retroperitoneal Volumetric Binder Mapping.
- Clinical Index: Maintain high suspicion for massive retroperitoneal bleeding in patients with high-impact deceleration or crush injuries.
- Pelvic Stabilization: Apply a commercial pelvic binder (or sheet wrap) immediately, centering it precisely over the greater trochanters to reduce pelvic volume.
- Avoid Manual Manipulation: Avoid repeated checks for pelvic instability via manual compression to prevent the disruption of established retroperitoneal clots.
- Hemodynamic Support: Initiate rapid uncrossed blood product transfusions per the established Massive Transfusion Protocol (MTP).
- Interventional Control: Mobilize interventional radiology (IR) instantly for pelvic angiography and selective coil embolization of active arterial bleeding sites.
- Surgical Backup: Consult orthopedic and trauma surgery services for urgent external fixation or pre-peritoneal packing if the patient remains hemodynamically unstable.
Pelvic Fracture with Bleeding
High-Energy Pelvic Ring Disruption & Retroperitoneal Volumetric Binder Mapping.
- Clinical Index: Maintain high suspicion for massive retroperitoneal bleeding in patients with high-impact deceleration or crush injuries.
- Pelvic Stabilization: Apply a commercial pelvic binder (or sheet wrap) immediately, centering it precisely over the greater trochanters to reduce pelvic volume.
- Avoid Manual Manipulation: Avoid repeated checks for pelvic instability via manual compression to prevent the disruption of established retroperitoneal clots.
- Hemodynamic Support: Initiate rapid uncrossed blood product transfusions per the established Massive Transfusion Protocol (MTP).
- Interventional Control: Mobilize interventional radiology (IR) instantly for pelvic angiography and selective coil embolization of active arterial bleeding sites.
- Surgical Backup: Consult orthopedic and trauma surgery services for urgent external fixation or pre-peritoneal packing if the patient remains hemodynamically unstable.
Compartment Syndrome
Closed Osteofascial Hypertension & Emergent Surgical Fasciotomy Mapping.
- Clinical Assessment: Assess the limb systematically for the classic 6 Ps: Pain out of proportion, Poikilothermia, Pallor, Paresthesia, Pulselessness, and Paralysis.
- Early Detection: Recognize that severe pain during passive stretching of the affected muscle group is the earliest and most reliable clinical sign.
- Pressure Monitoring: Measure osteofascial compartment pressures directly using a manometric needle transducer system.
- Diagnostic Thresholds: Confirm diagnosis if the delta pressure (Diastolic Blood Pressure minus Compartment Pressure) is ≤ 30 mmHg.
- Limb Positioning: Maintain the affected limb at heart level; do not elevate or apply ice, as this may further compromise perfusion.
- Surgical Intervention: Secure emergency orthopedic or general surgery consultation for immediate, full-length operative fasciotomy execution.
Toxicology / Environmental
Opioid Overdose
Mu-Receptor Agonist Overactivation & Respiratory Ventilation Mapping.
- Clinical Recognition: Identify the pathognomonic triad: respiratory depression, miosis (pinpoint pupils), and depressed sensorium.
- Airway Management: Establish immediate bag-valve-mask (BVM) ventilations with high-flow oxygen to treat severe hypercapnia/hypoxia.
- Pharmacologic Reversal: Administer titrated doses of Naloxone (0.4–2 mg IV, IM, or intranasal) to recover spontaneous, adequate respiratory effort.
- Dose Calibration: Avoid large, aggressive boluses to prevent precipitating sudden, severe opioid withdrawal or acute non-cardiogenic pulmonary edema.
- Observation Period: Monitor the patient continuously for a minimum of 4–6 hours, anticipating the potential for re-sedation as the opioid half-life exceeds the naloxone half-life.
- Extended Management: Consider a continuous intravenous Naloxone infusion if a long-acting or extended-release opioid ingestion is confirmed.
Benzodiazepine Overdose
GABA-A Receptor Hyper-Sedation & Airway Preservation Mapping.
- Clinical Assessment: Evaluate neurological and ventilatory competence; track symptoms including ataxia, slurred speech, and progressive somnolence.
- Airway Support: Secure and support the airway with supplemental oxygen; prepare for endotracheal intubation if respiratory depression or protective reflex loss occurs.
- Flumazenil Caution: Strictly avoid routine administration of Flumazenil in undifferentiated, mixed-substance, or chronic benzodiazepine-dependent overdoses.
- Seizure Risk: Recognize that Flumazenil administration in habitual users can precipitate severe, refractory, and potentially fatal withdrawal seizures.
- Tox-Screening: Obtain a comprehensive toxicology screening array to rule out concurrent ingestion of cardiotoxic or other sedative substances.
- Serial Monitoring: Implement close, serial clinical monitoring for respiratory depression and aspiration risk factors in a high-acuity setting (ED or ICU).
Organophosphate Poisoning
Acetylcholinesterase Inhibition Crisis & Cholinergic Toxidrome Mapping.
- Personal Safety: Ensure comprehensive Personal Protective Equipment (PPE) for all medical personnel prior to any patient contact to prevent secondary exposure.
- Decontamination: Remove all contaminated clothing instantly and thoroughly wash the patient's skin using soap and water to prevent ongoing absorption.
- Clinical Recognition: Identify the acute SLUDGEM (Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis, Miosis) toxidrome, specifically monitoring for life-threatening bronchorrhea and bradycardia.
- Atropinization: Administer Atropine 2–5 mg IV every 5–10 minutes, doubling the dose sequentially until airway secretions (bronchorrhea) resolve.
- Reactivation Therapy: Concurrently infuse Pralidoxime (2-PAM) as a 1–2 g IV loading dose over 30 minutes to facilitate acetylcholinesterase reactivation.
- Airway Management: Monitor oxygenation parameters continuously and aggressively manage copious bronchial secretions using frequent/continuous inline suctioning.
Carbon Monoxide Poisoning
Carboxyhemoglobin Disregard & Tissue Hypoxia Normobaric Oxymetry Mapping.
- Initial Resuscitation: Apply 100% high-flow supplemental oxygen immediately via a tight-fitting non-rebreather face mask.
- Pulse Oximetry Limitation: Understand that standard pulse oximetry devices cannot differentiate carboxyhemoglobin (COHb) from oxyhemoglobin, leading to falsely normal SpO2 readings.
- Diagnostic Sampling: Draw an arterial or venous blood gas (co-oximetry) sample immediately to measure precise carboxyhemoglobin (COHb) levels.
- Normobaric Clearance: Maintain high-flow normobaric oxygen therapy to accelerate the clearance half-life of CO to approximately 90 minutes.
- Hyperbaric Referral: Coordinate urgent transfer for hyperbaric oxygen (HBO) therapy if COHb levels exceed 25% (or > 15% in pregnancy).
- Clinical Thresholds: Utilize HBO therapy regardless of absolute COHb levels if the patient exhibits severe manifestations, such as altered mental status, syncope, or signs of myocardial ischemia.
Methanol / Ethylene Glycol Toxicity
Toxic Alcohol Biotransformation & Osmolar Gap Mitigation Mapping.
- Clinical Recognition: Identify a severe elevated anion gap metabolic acidosis (HAGMA) paired with an elevated calculated serum osmolar gap.
- Enzyme Inhibition: Administer Fomepizole (15 mg/kg IV loading dose) immediately to competitively inhibit alcohol dehydrogenase (ADH).
- Alternative Therapy: Initiate a titrated intravenous Ethanol infusion if Fomepizole is unavailable.
- pH Management: Infuse Sodium Bicarbonate IV to maintain a systemic pH > 7.30, which helps mitigate the tissue penetration of toxic organic acids.
- Adjunctive Cofactors: Deliver IV Thiamine and Pyridoxine (for Ethylene Glycol) or Leucovorin/Folate (for Methanol) to promote the metabolism of non-toxic pathways.
- Definitive Care: Consult nephrology for emergent hemodialysis if severe refractory metabolic acidosis, acute kidney injury (AKI), or visual deficits/end-organ damage occur.
Drug-Induced Cardiotoxicity (TCA Overdose)
Myocardial Fast Sodium Channel Blockade & QRS Narrowing Mapping.
- ECG Monitoring: Obtain serial 12-lead ECGs to monitor for QRS widening (> 100 ms) and the characteristic terminal R wave in lead aVR (indicator of high seizure/arrhythmia risk).
- Alkalinization Therapy: Administer an immediate IV bolus of 1–2 mEq/kg of 8.4% Sodium Bicarbonate if the QRS complex > 100 ms.
- Titration Goal: Repeat Sodium Bicarbonate boluses sequentially until a target systemic arterial pH of 7.45–7.55 is achieved.
- Mechanism: Understand that the hypertonic sodium load and induced alkalosis effectively displace TCAs from myocardial fast sodium channels.
- Hemodynamic Support: Initiate aggressive crystalloid volume expansion and norepinephrine infusions for hypotension/vascular shock.
- Rescue Strategy: Maintain continuous cardiac telemetry; prepare for Lipid Emulsion Therapy (ILE) if refractory arrhythmia or cardiac arrest thresholds are breached.
Heat Stroke
Severe Hyperthermic Multi-System Organ Failure & Core Cooling Mapping.
- Clinical Diagnosis: Confirm an elevated core body temperature exceeding 40°C (104°F) paired with significant central nervous system dysfunction (e.g., confusion, seizure, coma).
- Rapid Cooling: Initiate aggressive cooling immediately, targeting a core temperature reduction to below 39°C (102.2°F).
- Evaporative Cooling: Utilize evaporative cooling by spraying the patient with tepid water while exposing them to high-velocity air (fans).
- Conductive Cooling: Alternatively, utilize large-surface conductive cooling, such as continuous ice-water immersion, which is highly effective in exertional heat stroke.
- Avoid Antipyretics: Strictly avoid Acetaminophen or NSAIDs; they are ineffective in heat stroke and may exacerbate secondary hepatic or renal injury.
- Systemic Complications: Monitor continuously for signs of rhabdomyolysis, coagulopathy (DIC), and acute kidney injury resulting from the systemic inflammatory response.
Hypothermia
Core Thermal Depletion & Myocardial Arcs Rewarming Mapping.
- Thermal Monitoring: Measure exact core body temperatures using low-reading rectal or esophageal thermal probes.
- Patient Handling: Handle the patient with extreme gentleness; rough movement can precipitate refractory ventricular fibrillation in a cold, irritable myocardium.
- Passive Rewarming: Remove all wet clothing immediately and initiate passive external rewarming using heavy insulating blankets.
- Active External Rewarming: Deploy active external rewarming setups (e.g., forced-air warming blankets) primarily to the torso to prevent "afterdrop" from cold peripheral blood.
- Active Internal Rewarming: Provide active internal rewarming via infusion of heated intravenous crystalloids (38–42°C) and delivery of warmed, humidified oxygen.
- Advanced Cardiac Life Support (ACLS): Understand that the hypothermic myocardium is often resistant to standard antiarrhythmic drugs and defibrillation; focus on rewarming until core temperatures exceed 30°C.
Obstetric & Perioperative Emergencies
Eclampsia / Severe Preeclampsia
Gestational Vasospastic Hypertension & Myocardial Membrane Shielding Mapping.
- Seizure Prophylaxis: Initiate Magnesium Sulfate immediately: give a 4–6 g IV loading dose over 20 minutes, followed by a 2 g/h continuous infusion.
- Antihypertensive Therapy: Administer IV Labetalol (20–40 mg) or Hydralazine (5–10 mg) to control severe blood pressure thresholds ≥ 160/110 mmHg.
- Toxicity Monitoring: Monitor for signs of Magnesium toxicity, specifically tracking depressed or absent deep tendon reflexes, respiratory depression, or oliguria.
- Antidote: Keep Calcium Gluconate (1 g IV) at the bedside as the immediate first-line antidote for clinical magnesium toxicity.
- Laboratory Screening: Order serial laboratory evaluations (CBC, LFTs, LDH, uric acid) to screen for HELLP syndrome and worsening thrombocytopenia.
- Definitive Care: Coordinate with the obstetric team for urgent, definitive delivery of the fetus and placenta, which is the only cure for eclampsia.
Postpartum Hemorrhage
Uterine Atony Hypovolemia & Systematic Mechanical-Pharmacological Rescue Mapping.
- Mechanical Stimulation: Perform continuous, vigorous bimanual uterine massage immediately to stimulate myometrial contraction.
- First-Line Pharmacotherapy: Establish an aggressive IV Oxytocin infusion (20–40 units in 1L of balanced crystalloid) to treat the primary cause: Uterine Atony.
- Secondary Uterotonics: Administer second-line agents sequentially if bleeding persists: IM Methylergonovine or rectal/sublingual Misoprostol (800 mcg).
- Antifibrinolytic Therapy: Infuse Tranexamic Acid (TXA) 1 g IV within 3 hours of delivery to arrest pathological fibrinolysis.
- Structural Assessment: Thoroughly inspect the placenta for completeness and examine the lower genital tract to exclude retained fragments or lacerations.
- Escalation: Activate the Massive Transfusion Protocol (MTP) and prepare for mechanical intervention, such as intrauterine balloon tamponade or emergency surgical compression (e.g., B-Lynch suture).
Amniotic Fluid Embolism
Anaphylactoid Circulatory Collapse & Advanced Consumptive Coagulopathy Mapping.
- Airway & Breathing: Intubate early and apply 100% mechanical ventilatory support to correct profound hypoxemia.
- Hemodynamic Support: Anticipate rapid right-sided cardiogenic shock (pulmonary hypertension) and support perfusion with targeted inotropes/vasopressors (e.g., norepinephrine, milrinone).
- Aggressive Coagulopathy Management: Initiate an emergency, hyper-aggressive Massive Transfusion Protocol (MTP) to treat the profound consumptive Disseminated Intravascular Coagulation (DIC).
- Directed Replacement: Transfuse large quantities of cryoprecipitate (fibrinogen replacement), fresh frozen plasma, and platelets, ideally guided by rapid viscoelastic testing (TEG/ROTEM).
- Adjunctive Therapy: Consider the "A-OK" protocol (Atropine, Ondansetron, and Ketorolac) as an experimental/supportive strategy for blocking the anaphylactoid response.
- Advanced Rescue: Prepare for emergent mechanical circulatory support (e.g., VA-ECMO) if cardiovascular collapse remains refractory to standard resuscitation.
Obstetric Sepsis
Gestational Genitourinary Translocation & Maternal-Fetal Resuscitation Mapping.
- Clinical Recognition: Recognize early clinical deterioration by adjusting traditional SIRS/qSOFA criteria to account for normal pregnancy-related physiological baselines (e.g., increased baseline heart rate and decreased systemic vascular resistance).
- Source Identification: Obtain blood cultures and targeted genitourinary/cervical/placental cultures prior to the initiation of empiric antimicrobial therapy.
- Empiric Antibiotics: Administer broad-spectrum empiric IV antibiotics within the "Golden Hour," selecting agents that are both effective and safe for gestational physiology.
- Goal-Directed Resuscitation: Apply cautious, balanced crystalloid fluid resuscitation, strictly monitoring for maternal pulmonary edema, which occurs more readily in pregnancy due to decreased colloid oncotic pressure.
- Fetal Monitoring: Maintain continuous electronic fetal monitoring (EFM) to identify signs of progressive fetal distress or hypoxemia, which may precede maternal hemodynamic collapse.
- Source Control: Coordinate with obstetric surgical teams early to identify and address any uterine, placental, or retained tissue sources of infection (e.g., D&C, hysterectomy).
Difficult Airway
Anticipated Airway Anatomy Distortion & Visual Algorithmic Sequence Mapping.
- Pre-Induction Assessment: Perform a comprehensive evaluation, including Mallampati score, thyromental distance, and mouth opening, to identify potential anatomical challenges.
- Patient Positioning: Meticulously position the patient in a sniffing or ramped configuration (especially in obstetric patients) to optimize the pharyngeal, laryngeal, and oral axes for laryngoscopy.
- Pre-oxygenation: Ensure high-flow nasal oxygenation (HFNO) is active throughout pre-oxygenation and into the apneic window to extend safe apnea margins.
- Cognitive Readiness: Maintain a visible cognitive aid (e.g., DAS guidelines) and ensure a fully unpacked, standardized difficult airway rescue cart is immediately available.
- Primary Strategy: Utilize video laryngoscopy (VL) as the primary intubation device if anatomical markers or patient history indicate a high probability of a difficult airway.
- Team Briefing: Establish an explicit verbal pre-briefing with the team to clarify roles, assign rescue backup duties (e.g., "cannot intubate, cannot oxygenate" plan), and ensure shared situational awareness.
Failed Intubation
Multiple Laryngoscopy Attempt Termination & Supraglottic Oxygenation Rescue Mapping.
- Formal Declaration: Declare a formal "failed intubation" sequence aloud immediately after two unsuccessful, fully optimized attempts.
- Trauma Mitigation: Halt all further blind or repetitive laryngoscopy attempts to prevent iatrogenic airway trauma, bleeding, and further edema.
- Oxygenation Priority: Focus all immediate efforts on oxygenation; insert a second-generation Supraglottic Airway (e.g., LMA) instantly to secure the airway.
- BVM Rescue: If SGA placement is unsuccessful, utilize a two-person Bag-Valve-Mask (BVM) technique with oral/nasal airways to maintain oxygenation.
- CICO Decision Point: Transition immediately to the "Cannot Intubate, Cannot Oxygenate" (CICO) protocol if oxygen saturations fall below 80% or clinical signs of hypoxemia worsen.
- Surgical Rescue: Execute an immediate surgical cricothyroidotomy (scalpel-bougie technique) to secure the airway without further delay.
Malignant Hyperthermia
Uncontrolled Intracellular Calcium Leak & Ryanodine Receptor Antagonism Mapping.
- Early Recognition: Recognize the pathognomonic early indicators: sudden, unexplained rise in end-tidal CO2 (EtCO2), tachycardia, and generalized muscle rigidity (especially after succinylcholine).
- Trigger Termination: Discontinue all volatile halogenated anesthetics and succinylcholine immediately.
- Circuit Management: Purge the anesthesia machine circuits using high-flow (10 L/min) 100% oxygen; if available, attach activated charcoal filters to the inspiratory and expiratory ports.
- Pharmacologic Rescue: Administer Dantrolene 2.5 mg/kg IV push rapidly. Repeat dose as needed until metabolic signs and muscle rigidity resolve.
- Aggressive Cooling: Deploy rapid cooling: infuse chilled intravenous saline, consider body cavity lavage, and apply surface ice/cooling blankets.
- Metabolic Correction: Treat severe metabolic acidosis with Sodium Bicarbonate and manage life-threatening hyperkalemia with Insulin/Dextrose or Calcium Chloride shifts.
Local Anesthetic Systemic Toxicity (LAST)
Voltage-Gated Sodium Channel Deactivation & Lipid Sink Scavenging Mapping.
- Termination: Stop the local or regional anesthetic injection immediately upon the development of prodromal symptoms (perioral numbness, metallic taste, tinnitus).
- Airway & Ventilation: Secure the airway and administer 100% oxygen; hypoxia and acidosis dramatically lower the threshold for LAST-driven cardiac dysrhythmias.
- Seizure Management: Administer IV Benzodiazepines promptly for tonic-clonic seizures, as these increase the metabolic demand and acidemia.
- Lipid Resuscitation: Initiate 20% Intralipid emulsion (ILE) therapy immediately: 1.5 mL/kg IV bolus over 1 minute, followed by a 0.25 mL/kg/min continuous infusion.
- Cardiac Support: Continue ACLS efforts if cardiac arrest occurs. Avoid using Lidocaine (as it is a local anesthetic) and limit Epinephrine doses to < 1 mcg/kg.
- Advanced Rescue: Alert the nearest cardiothoracic/ECMO team early, as patients with refractory arrest from LAST are ideal candidates for mechanical circulatory support.
ICU Syndromes / System Failure States
Acute Respiratory Failure (Ventilated Patient)
Mechanical Ventilatory Decompensation & Algorithmic DOPES Rescue Mapping.
- Initial Stabilization: Identify sudden ventilatory distress or high-pressure alarms; disconnect the patient from the ventilator circuit immediately and initiate manual bag-valve-mask (BVM) ventilation with 100% oxygen to gauge lung compliance.
- Systematic Assessment (DOPES):
- D - Displacement: Verify ETT depth and ensure the tube has not migrated into the right mainstem bronchus or out of the trachea.
- O - Obstruction: Suction the airway immediately to rule out thick mucous plugs or kinking of the endotracheal tube.
- P - Pneumothorax: Assess for asymmetric chest rise, absent breath sounds, and hemodynamic collapse; prepare for immediate needle decompression or chest tube insertion.
- E - Equipment: Verify the integrity of the ventilator circuit, power source, and oxygen supply.
- S - Stacking (Auto-PEEP): Evaluate for auto-PEEP; allow for prolonged expiratory times or disconnect the circuit to allow complete lung emptying.
- Troubleshooting: Adjust ventilator settings as indicated by the findings, focusing on correcting trigger sensitivity or expiratory flow limitations.
Ventilator-Associated Pneumonia (VAP)
Nosocomial Parenchymal Invasion & Subglottic Secretion Mitigation Mapping.
- Diagnostic Criteria: Identify new or progressive pulmonary infiltrates on chest X-ray developing after ≥ 48 hours of mechanical ventilation, paired with systemic signs.
- Systemic Markers: Monitor for fever, leukocytosis (or leukopenia), and newly purulent endotracheal secretions.
- Aspiration Prevention: Maintain the head of the bed (HOB) strictly elevated at 30–45 degrees to minimize silent gastric micro-aspiration of colonized secretions.
- Secretions Management: Utilize specialized endotracheal tubes equipped with subglottic secretion suctioning ports, applying regular continuous or intermittent subatmospheric pressure.
- Microbiological Sampling: Obtain a quantitative or semi-quantitative deep endotracheal aspirate (ETA) or bronchoalveolar lavage (BAL) sample for culture and susceptibility testing.
- Empiric Therapy: Initiate broad-spectrum IV antimicrobials targeted toward local institutional antibiograms and individual patient risk factors for multidrug-resistant (MDR) organisms.
Central Line-Associated Bloodstream Infection (CLABSI)
Indwelling Catheter Endovascular Colonization & Sterile Insertion Bundle Mapping.
- Clinical Suspicion: Suspect CLABSI when new-onset fever, rigors, or unexplained hypotension develop in a patient with an indwelling central venous catheter (CVC) and no other identifiable infection source.
- Prevention (Insertion Bundle): Adhere strictly to CVC insertion bundles: utilize maximum sterile barrier precautions (cap, mask, sterile gown, sterile gloves, full-body drape) and chlorhexidine-based skin antisepsis.
- Diagnostic Sampling: Draw simultaneous quantitative blood cultures from the indwelling central lumen and a separate peripheral venipuncture site.
- Differential Time to Positivity (DTP): A DTP > 2 hours (line culture positive before peripheral culture) is a highly specific indicator of catheter-related infection.
- Empiric Therapy: Start empiric broad-spectrum IV Vancomycin; add gram-negative coverage (e.g., Ceftazidime or Piperacillin-Tazobactam) based on clinical severity, prior colonization, and institutional epidemiology.
- Source Control: Assess the insertion site daily for erythema, tenderness, or purulence; execute prompt catheter removal if virulent pathogens (e.g., *Staphylococcus aureus*, *Candida* spp., or *Pseudomonas*) are identified.
Central Line-Associated Bloodstream Infection (CLABSI)
Indwelling Catheter Endovascular Colonization & Sterile Insertion Bundle Mapping.
- Clinical Suspicion: Suspect CLABSI when new-onset fever, rigors, or unexplained hypotension develop in a patient with an indwelling central venous catheter (CVC) and no other identifiable infection source.
- Prevention (Insertion Bundle): Adhere strictly to CVC insertion bundles: utilize maximum sterile barrier precautions (cap, mask, sterile gown, sterile gloves, full-body drape) and chlorhexidine-based skin antisepsis.
- Diagnostic Sampling: Draw simultaneous quantitative blood cultures from the indwelling central lumen and a separate peripheral venipuncture site.
- Differential Time to Positivity (DTP): A DTP > 2 hours (line culture positive before peripheral culture) is a highly specific indicator of catheter-related infection.
- Empiric Therapy: Start empiric broad-spectrum IV Vancomycin; add gram-negative coverage (e.g., Ceftazidime or Piperacillin-Tazobactam) based on clinical severity, prior colonization, and institutional epidemiology.
- Source Control: Assess the insertion site daily for erythema, tenderness, or purulence; execute prompt catheter removal if virulent pathogens (e.g., *Staphylococcus aureus*, *Candida* spp., or *Pseudomonas*) are identified.
ICU Delirium
Acute Neuro-Metabolic Fluctuating Encephalopathy & Cognitive ABCDEF Bundle Mapping.
- Routine Screening: Screen all intensive care patients twice daily using the validated Confusion Assessment Method for the ICU (CAM-ICU) or the Intensive Care Delirium Screening Checklist (ICDSC).
- Diagnostic Criteria: Evaluate for acute fluctuations in attention, disorganized thinking, or altered baseline levels of consciousness.
- Systematic Management (ABCDEF Bundle):
- A: Assess, prevent, and manage pain.
- B: Both SAT (Spontaneous Awakening Trials) and SBT (Spontaneous Breathing Trials).
- C: Choice of sedation and analgesia (avoiding benzodiazepines).
- D: Delirium: Assess, prevent, and manage.
- E: Early mobility and exercise.
- F: Family engagement and empowerment.
- Non-Pharmacological Care: Prioritize sleep hygiene (e.g., earplugs, eye masks), maintain natural day-night light cycles, and provide frequent reorientation.
- Medication Stewardship: Minimize the use of deliriogenic medications; strictly avoid continuous benzodiazepine infusions unless medically indicated (e.g., alcohol withdrawal).
- Functional Recovery: Engage physical and occupational therapy early to facilitate mobility and safe out-of-bed activity, which are potent stimuli for cognitive recovery.
ICU-Acquired Weakness
Diffuse Symmetrical Neuromuscular Sarcopenia & Early Kinesiology Mobilization Mapping.
- Clinical Recognition: Recognize acute, symmetrical, diffuse muscle weakness (ICU-acquired quadriparesis) often presenting with flaccidity and diminished or absent deep tendon reflexes.
- Differential Diagnosis: Differentiate Critical Illness Polyneuropathy (CIP) and Critical Illness Myopathy (CIM) from acute spinal cord injury, Guillain-Barré syndrome, or central structural events through clinical assessment and, if necessary, electrodiagnostic studies.
- Prevention of Atrophy: Avoid prolonged, unnecessary therapeutic immobilization by instituting early, structured physical rehabilitation arcs as soon as hemodynamic stability is achieved.
- Medication Stewardship: Minimize the duration and dosage of continuous neuromuscular blocking agents (NMBAs) and high-dose IV corticosteroids, as their synergy significantly increases risk.
- Metabolic Optimization: Target intensive, patient-specific blood glucose control protocols, as hyperglycemia is a recognized contributor to metabolic neuro-axonal damage.
- Serial Monitoring: Evaluate and document Medical Research Council (MRC) sum scores serially (e.g., weekly) to objectively track upper and lower extremity recovery vectors.
Prolonged Mechanical Ventilation Syndrome
Diaphragmatic Myopathy Deconditioning & Standardized Spontaneous Weaning Mapping.
- Definition: Identify patients requiring prolonged mechanical ventilation (PMV), typically defined as ≥ 21 consecutive days of support.
- Readiness Screening: Screen daily using standardized safety parameters: adequate oxygenation ($PaO_2/FiO_2 > 200$), hemodynamic stability (minimal vasopressors), and absence of active sedation.
- Weaning Trials: Execute a daily Spontaneous Breathing Trial (SBT) using low pressure support (e.g., 5-8 cm H2O) or a T-piece configuration to assess tolerance.
- Objective Assessment: Calculate the Rapid Shallow Breathing Index (RSBI = $RR / V_t$ in liters); an RSBI < 105 is generally predictive of successful extubation.
- Barrier Identification: Systematically address reversible weaning barriers, including electrolyte imbalances (e.g., hypophosphatemia, hypokalemia), fluid overload, and protein-calorie malnutrition.
- Advanced Care Planning: Coordinate early with surgical teams for elective tracheostomy if weaning is protracted, as this improves patient comfort, reduces sedation needs, and facilitates early mobilization.